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Mammary cancer currently kills 30,000 people each year in the 
United States and the number is growing (1). As with most cancers, 
probably no one cause is responsible for the many different types of 
malignant and benign breast diseases. Since attempts to link verti-
cal transmission of a virus with mammary cancer have as yet failed, 
the hope for a quick cure by a polio-type immunization with an attenu-
ated virus has diminished. The best chance for survival still rests 
with early detection, mastectomy, irradiation, chemotherapy, and 
immunotherapy. 
Prevention and more effective treatment are clearly dependent 
upon a better understanding of the biochemical errors that produce 
the state termed cancer. This requires careful analysis of human 
breast diseases to determine whether such factors as estrogen and 
prolactin receptors correlate with hormonal sensitive growth, whether 
embryonic proteins become re-expressed, and most importantly whether 
or not the differentiation of breast diseases encompasses a wide 
spectrum. If a wide range of biochemical differentiation is found, 
the general methods currently used to treat pre- and post-menopausal 
breast lesions may need to be modified to suit the individual tumor. 
The development of animal models that closely resemble the 
human situation is, for obvious reasons, extremely important. In 
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order to assess the biological status of mammary epithelial cells in 
both animal and human tumors, it is necessary to utilize indicators 
which are unique for di-fferentiated mammary epithelial cells. The 
indicator must be found in measurable amounts, must be stable, and 
purifiable to homogeneity. These requirements are fulfilled by a-lact-
albumin. This protein, totally unique to maT1111ary epithelial cells, is 
found in high concentration in the secretory cells only during lacta-
tion, and follows the cyclic production of milk from preparturition 
through regression (2). In 1964 Ebner and Brodbeck {3) first described 
the biological function of a-LA, which serves as a modifier protein for 
a galactosyltransferase by lowering the Km of glucose from molar to 
millimolar so that lactose production can proceed at a significant 
rate. Enzymatic measurement of low levels of a-LA by incorporation of 
radioactive galactose from UDP-galactose into lactose proved unsatis-
factory in tissues due to the presence of enzymes which hydrolyze UDP-
galactose. To circumvent these problems, radioimmunoassays for human 
and rat a-LA were developed. These assays provide a thousand fold 
increase in sensitivity, are specific for a-LA, are very reproducible, 
and are accurate. By measuring the level of a-LA in breast lesions, 
one can estimate the degree of lactation, or in other terms, estimate 
the state of differentiation of the tissue. Metastases to different 
tissues can be compared with the primary tumor and thereby provide 
information on the state of differentiation required by the metasta-. 
sizing process. Other breast diseases such as benign fibrocystic 
disease, gynecomastia, and galactorrhea can be examined in order to 
detennine if these diseases should be considered as valid precancerous 
states. 
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Since a-LA appears in the blood during lactation, it is of inter-
est to determine the feasibility of using elevated serum or urinary 
a-LA levels to screen populations for early detection of breast lesions 
which produce a-LA. In addition, it might be possible to evaluate the 
effectiveness of surgery which attempted to remove all the primary 
focus and metastases. 
There have been many attempts to develop model systems for human 
breast cancer. The Mason Tumor Bank maintains a number of the success- . 
fully transplanted animal tumor lines, but the only distinction made at 
present is based upon histological appearance. Numerous attempts have 
been made to establish and maintain human mammary carcinoma cells in 
cell cultures, and a number of such cultures are available. Recently, 
there have been claims based upon karyotypical and isoenzyme markers 
that these lines have been contaminated and eventually overgrown by 
Hela cells (4). Measurement of a-LA levels could help to establish the 
parentage and degree of differentiation of these and other cell lines. 
Immunofluorescence and the horseradish peroxidase techniques 
provide other methods of localizing and detecting a-LA in tissue sec-
tions. Much controversy exists in several breast diseases, such as 
Paget•s disease and ductal/lobular carcinomas with respect to the 
parentage and differentiation of the malignant cells. Since isolation 
of these cell types is impossible, localization of a-LA within a cell 
population of a tissue would be clinically very beneficial. 
Every mammal•s milk contains immunoglobulins, yet mammary epi-
thelial cells do not synthesize y~globulins. Instead, y-globulins are 
produced in the blood by the plasma cells and by some mechanism are 
transported through the mammary epithelial cells and secreted with 
the milk. The process is selective for certain y-globulins and is 
a form of active transport since milky-globulin concentrations can 
be higher than serum y-globul'in levels. By di:rectly labeling pure 
y-globulins with fluorescein, one can investigate the extent of y-
globulin receptors on cells and their specificity. 
In this study, radioimmunoassays were developed for rat and 
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human a-LA and levels of a-LA were determined in rat and human tumors 
in order to assess the value of this assay for tumor detection. In 
addition, immunofluorescence and peroxidase coupled antibodies to a-LA 
were used to localize a-LA in tissue sections. Such assays were com-
plicated by the presence of y-globulin receptors on the mammary epi-
thelial cells and this was circumvented by pretreatment with formalin 
or blocking y-globulins. 
CHAPTER II 
LITERATURE REVIEW 
Hormonal Regulation of Gene Expression 
in Mammary Cells 
In order to designate the biochemical lesions in breast cancer, 
it is necessary to understand the intricate and unique biochemistry 
of the normal alveolar cell. During pregnancy the mammary gland under-
goes remarkable developmental changes related to the formation of an 
exocrine gland that will form and secrete the specialized components of 
milk after parturition. This complex process of growth and differ-
entiation is regulated by a large number of intracellular molecular 
mechanisms, which in turn are governed by a complex set of specific 
hormonal signals. 
Growth of the mammary gland proceed~ through a process of cell 
proliferation rather than by hypertrophy of existing cellular units (5). 
Several hormones have been found to regulate the proliferation of 
mouse midpregnant mammary epithelial cells in organ culture. Time 
course studies of DNA synthesis in midpregnant mammary explants showed 
that insulin stimulates an approximate three-fold increase in the 
rate of synthesis, with the maximal rate observed at about 24 hours; 
and after a partially synchronized wave of DNA synthesis, cellular 
proliferation virtually ceases after about 96 hours of incubationo 
This stimulation represents an increase in the number of epithelial 
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cells induced to replicate DNA as indicated by mitotic indexes. Pre-
parations of pituitary growth hormone and epithelial-epidermal. growth 
factor also induce·an increase in the number of epithelial cells to 
enter the S (DNA synthesis) phase of the cell cycle (6). In contrast 
to the single wave of DNA synthesis induced oy insulin, epidermal 
growth factor, or growth hormone, the. addition of serum to the chemi-
cally defined medium induces several waves of DNA synthesis which con-
tinue for prolonged periods of culture (7). The activity in serum 
which induces the proliferation has been partially purified from human 
serum, and appears to be a heat labile, low molecular weight poly-
peptide whose activity is not neutralized by antisera which inactivate 
insulin, growth hormone, or epidermal growth factor. The partially 
purified factor is effective at even 10% of its normal serum concentra-
tion~ In contrast, the minimal effective concentration of insulin 
in vitro is about 50 fold greater than normal physiological conditions. 
Although epidermal growth factor is effective at normal serum levels, 
it has been detected only in the serum of the mouse, rat, and rabbit 
(8). 'Because of this narrow species distribution, epidermal growth 
factor may not be of general importance in the regulation of manunary 
gland growth. 
Studies on the effect of estradiol-17~ on cell proliferation in 
mid-pregnant explants have indicated a possible role for this hormone 
in the regulation of mammary epithelial cell proliferation. Addition 
of estradiol-17a to the serum-free chemically defined culture media 
has little effect on cell proliferation in the absence of insulin. 
However, under conditions in which cells are induced to initiate DNA 
synthesis, such as in the presence of insulin, estradiol-17e is found 
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to exert a concentration dependent permissive effect (9). At lo-12 M 
concentration, estradiol-l7s markedly inhibits DNA synthesis, mitotic 
activity, and the induction of DNA polymerase. As the concentration 
of estradiol-l7s is increased over the physiological range (10) to a 
concentration of lo-10 M, DNA synthesis increases to approximately the 
maximal rate induced by insulin. Autoradiographic studies demonstrated 
that these effects relate to the numbers of cells which enter the S 
phase rather than to the rate of DNA replication per cell. The inhibi-
tory concentration of estradiol-17S is similar to serum levels before 
puberty, a period in which mammary gland growth is largely prevented. 
The higher lo-10 M concentration is within levels found in the sera of 
adult women (11) and appears to permit maximum rates of induced cell 
proliferation. Mammary growth at puberty may, therefore, be mediated 
by a permissive effect of increasing serum concentrations of estradiol-
l7s by modifying the rate at which cells pass from the G phase into 
the S phase, although it does not seem to be a sufficient hormonal 
stimulus in itself to induce the initiation of DNA synthesis. 
In addition to the initiation of DNA replication, a number of 
other biosynthetic events related to chromosomal replication are induced 
in mammary epithelial cells in organ cultures containing insulin. After 
about 16 hours of incubation the maximum rate of incorporation of 3H 
amino acids into acidic chromatin is observed, and about eight hours 
later maximal rates of DNA synthesis, methylation of nascent DNA chains, 
DNA polymerase activity, and 14c amino acid incorporation into histones 
are seen (12). 
Hormonal induction of milk proteins has been studied in depth 
by using explants from mi"dpregnant mouse mammary glands which contain 
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two types of epithelial cells: secretory alveolar cells and undiffer-
entiated stem cells. Autoradiographi_c techniques have demonstrated 
that the secretory alveolar cells in the gland of pregnant or lactating 
~ice seldom di~ide (13). In contrast, the undifferentiated epithelial 
cells can be induced to divide by the previously stated methods. Tissues 
incubated in medium containing insulin, hydrocortisone, and prolactin 
are found to contain increased numbers of secretory alveolar cells, and 
to exhibit increased synthesis of milk proteins---a characteristic 
and unique activity of mammary alveolar cells (14). A characteristic 
sequence of hormonal actions is required for the induction of the milk 
proteins casein and lactose synthetase (15, 16, 17, 18, 19, 20). Several 
hormones may serve to regulate the rate of cell division among the 
undifferentiated stem cell population. A period of stimulation with 
hydrocortisone is required before milk protein synthesis can occur in 
the new daughter cells. In cells thus pretreated with insulin and 
hydrocortisone, prolactin or placental lactogen can synergize with 
insulin to induce milk protein formation (21, 22, 23). A characteristic 
sequence of molecular biosynthetic events occurs upon addition of 
prolactin to the medium. All of the increases in rates of synthesis 
depend upon prior completion of cell division, previous treatment 
with hydrocortisone and the concomitant, synergistic action of insulin. 
During the first 20 minutes following the addition of prolactin, a net 
increase in the rate of synthesis of rapidly labeled nuclear RNA 
and preribosomal RNA can be observed (24), followed by increased in-
corporation of radioactivity into ribosomal RNA and finally increased 
numbers of polysomes in the cytoplasm of the mammary epithelial cells 
(25). After four to six hours of incubation with prolactin, the 
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synthesis of all the components of casein is stimulated coordinately. 
After 12 hours of incubation, increases in the enzymatic activities 
of the two components of lactose synthetase, galactosyltransferase 
and a-lactalbumin, are observed. (4). The observation that the pro-
lactin-induced stimulation of milk protein synthesis is completely 
prevented by inhibitors of RNA synthesis, such as actinomycin D and 
mitomycin C, represents evidence that is consistent with the concept 
that the induction of these specific proteins is dependent upon the 
preceding increases in RNA formation. 
Differentiation of mammary epithelial cells during pregnancy in 
the mouse is associated with a marked increase in transfer RNA (tRNA) 
as indicated by amino acid acceptor activity and tRNA methylases (26). 
Formation of active tRNA is completed by methylation of the poly-
nucleotide RNA chain by a group of specific methylating enzymes. 
Characterization of hybridizable RNA in lactational cells has demon-
strated that these cells contain species of RNA which are not detecta-
ble in the undifferentiated cells by RNA-DNA hybridization competition 
experiments (27, 28). 
Demonstration that the hormone dependent differentiation of 
mammary epithelial cells is associated with marked activation of gene 
transcription which results in the formation of nRNAs that are not 
detectable in undifferentiated cells is consistent with the concept 
that hormone-dependent cell differentiation represents the derepression 
of specific genes in the differentiated cells which were not transcribed 
in the undifferentiated stem cells. 
To evaluate the potential role of specific proteins in the regula-
tion of gene activation and transcription, the synthesis of specific 
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nuclear proteins was studied by Marzluff et ~- (29). Studies on 
mammary epithelial cell histones have demonstrated that these proteins 
lack tissue or species specificity and therefore seem unlikely to 
contain the structural specificity anticipated for the recognition 
and regulation of specific nucleotide sequences of genes. In contrast, 
studies on mammary acidic chromatin protein have demonstrated that 
these proteins are extremely heterogeneous and are tissue and species-
specific, and could represent a class of proteins involved in the 
activation of specific genes. In other tissues this class of proteins 
has been reported to bind to the DNA of the tissue of origin only, 
and to modify the sequences of hybridizable RNA which are transcribed 
on reconstituted chromatin (30). Acrylamide gel electrophoresis in 
sodium dodecyl sulfate of highly purified preparations of acidic 
chromatin protein from virginal glands, and lactating mammary glands 
and liver reveal a complex of six proteins with low electrophoretic 
mobilities .in the lactational tissue which are not detectable in the 
preparations from undifferentiated mammary tissues or other mouse 
tissues (31). Incubation of developing mammary gland explants with 
insulin or serum causes a marked stimulation of incorporation of 
radioactivity into nearly all the acidic chromatin proteins, but incu-
bation with hydrocortisone and/or prolactin does not significantly 
affect the net rate of synthesis or turnover of these specific proteins. 
Thus, the synthesis of these acidic chromatin proteins is markedly 
altered by factors that affect cell proliferation, but is not regulated 
by the hormones which induce milk protein synthesis in differentiated 
alveolar cells (32). These observations suggest a tentative model 
for initial or early gene activation in mammary cell differentiation. 
Induction of DNA replication in the undifferentiated stem cells by 
either insulin or serum factor, with the possible permissive effect 
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of estradiol-178, is associated with the formation of new and unique 
acidic chromatin proteins which are specific for differentiated and 
lactation-inducible cells. The replication of DNA may thus represent 
the critical time during which new histones and acidic proteins may 
recombine with DNA in such a manner as to permit a new pattern of gene 
derepression in the daughter cells into which is segregated the newly 
snythesized DNA with its new unique nuclear proteins. Insulin or the 
serum factor thus appear to represent hormonal triggers which set in 
motion a sequence of intrinsic mechanisms which may lead to altered 
patterns of gene expression. 
Following this insulin-induced division-differentiation, a large 
number of molecular responses are observed in mammary epithelial cells 
after stimulation with prolactin. The first action of prolactin on 
its target cell appears to be the binding of prolactin to a hormone 
specific receptor site. Utilizing a binding assay with mouse mammary 
epithelial cell particles, Turkington (33) reported a rather prolactin-
specific saturable binding activity with a dissociation constant of 
9 x lo-9 M which had only about 27% displacement with bovine growth 
hormone. Specific binding activities in particles prepared from 
various organs of the mouse and rat showed the highest specific bind-
ing in lactating mammary gland with about one-third that binding in mid-
pregnant mammary glands, liver and kidney, and about one-tenth that 
binding in adrenal, ovary and seminal vesicles. No saturable binding 
activity was found in tissues where no physiological activity of pro-
lactin is known such as heart, lung, spleen, and cerebral cortex (34). 
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These data integrate well with prolactin's known ability to increase 
sodium readsorption in kidneys and its regulation of hepatic lipogenesis 
in migratory birds, as well as a trophic influence on the adrenal gland, 
and may suggest additional organs in which it may play a role (35). 
The prolactin receptor in mammary particles is degenerate in that it 
recognizes all lactogenic hormones, as seen by the ability of growth 
hormone and placental lactogen to displace prolactin from receptors, 
although prolactin is the most potent of the lactogenic hormones. The 
chemical nature of the prolactin binding activity in mouse and rabbit 
mammary gland particles was investigated by pretreatment with various 
enzymes, and binding was significantly decreased by treatment with 
trypsin and phospholipase-C, but was unaffected by collagenase, 
neuraminidase, RNase and DNase (36). A recent report by Chomczynski 
and Topper (37) indicated that placental lactogen and prolactin can 
stimulate the rate of RNA synthesis by nuclei isolated from mammary 
epithelial cells and suggested that these protein hormones may perform 
some of their functions within the mammary cell. 
Early studies on the hormonal regulation of mouse mammary epithe-
lial cells demonstrated that 32phosphorous was incorporated into speci-
fic histones and acidic nuclear proteins which were temporally 
associated with activation of transcription by insulin and prolactin 
(25). Because the phosphorylation represented early and dramatic 
effects of prolactin on DNA-associated proteins, investigators were 
interested in determining the mechanism by which protein phosphorylation 
is regulated in mammary epithelial cells. Protein kinase activity 
which exhibited a high substrate specificity for serine and threonine 
residues of nuclear proteins was purified from lactating mammary gland 
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by Majumder and Turkington (38). Two forms of the enzyme, both found 
in the cytosol, were resolved, with protein kinase II exhibiting the 
important property of activation by cyclic nucleotides. The apparent 
Km value for cAMP was 0.03 ~M, whereas activation with other cyclic 
nucleotides was in the range of one to three ~M. Protein kinase II 
was found in association with a specific cAMP-binding protein which 
could be dissociated by incubation with cAMP into a cAMP-binding sub-
unit and the activated catalytic subunit which is identical to protein 
kinase I. Levels of both protein kinases in mammary epithelial cells 
during cellular differentiation in vivo change coordinately, increasing 
dramatically during the first half of pregnancy until at parturition 
they exhibit a nine fold maximum over virginal tissue. In contrast 
to the hormonal induction of the milk proteins, which requires the 
action of insulin, hydrocortisone, and prolactin, the activities of 
the catalytic and regulatory subunits of protein kinase were increased 
by prolactin in cells previously treated only with insulin. Further-
more, the stimulation of the cAMP-binding activity by prolactin did 
not require the synergistic action of insulin, and in all cases, could 
be prevented by addition of actinonycin D or cyclohexamide to the 
culture at the same time prolactin was added. This suggests that 
induction of the kinase enzymes requires concomitant synthesis of RNA 
and protein (39). 
In order to elucidate the functional role of the hormonally 
induced protein kinase, the physiological substrates of the enzymes 
have been studied (40). The rates of phosphorylation of highly puri-
fied preparations of mammary cell membranes, ribosomes and histones 
by exogenous purified protein kinase were compared and histones were 
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labeled twelve times faster and ribosomal proteins were labeled two 
times faster than membrane proteins. The endogenous protein kinase 
activity of purified mammary plasma membranes and ribosomes was heat 
labile, not extracted by various detergents, and was not stimulated by 
cyclic nucleotides. The organelle associated proteins that were phos-
phorylated in mammary explants incubated with insulin, hydrocortisone, 
and prolactin, were further characterized by polyacrylamide gel electro-
phoresis and all nineteen phosphoproteins of the membrane showed a 
marked increase in rate of phosphorylation when compared with membranes 
from explants grown in only insulin and hydrocortisone. Four of the 
eight phosphorylated ribosomal proteins showed increased levels of phos-
phorylation, and these four specific proteins have been observed to 
increase in the mouse mammary gland during the stages of pregnancy. 
Studies were also carried out to correlate the time course of 
induction of the protein kinase with prolactin-mediated stimulation of 
protein p~osphorylation in vitro. In mammary explants pretreated with 
insulin and hydrocortisone and subsequently with prolactin, the cAMP-
dependent protein kinase II and the cAMP binding activity of the 
regulatory subunit were rapidly induced to maximal levels in one hour. 
Subsequently, there were marked increases in the rates of phosphoryla-
tion of proteins with the plasma membrane proteins reaching a maximal 
value at sixteen hours, and nuclear proteins at twenty-four hours. 
Similar observations were seen for insulin-induced protein kinase (41). 
Other highly significant observations concerning the action of 
prolactin on mammary epithelial cells must be considered before a final 
model can be assembled. The binding of prolactin to mammary particles 
does not activate adenylate cyclase ~vitro (38). This result suggests 
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that the prolactin receptor sites may not be functionally organized in 
the membrane in such a manner as to affect the activity of the membrane-
bound adenylate cyclase. Furthermore, since the uptake of large amounts 
of cAMP from the medium does not serve to substitute for the action of 
prolactin, it appears unlikely that the generation of cAMP by adenylate 
cyclase represents a direct step in the action of prolactin (38). A 
more reasonable model invokes the formation of the prolactin-receptor 
complex which serves to induce transcription by an unknown mechanism of 
RNAs necessary to synthesize more protein kinase molecules, which may 
then serve to propagate the initial action of prolactin throughout the 
many functionally distinct compartments of the mammary cell by phos-
phorylating specific protein components of the plasma membrane, ribo-
somes, and chromatin. 
Models for Malignancy 
During the last ten years observations have been made that have 
dramatically altered the general models for malignancy. Broadly organ-
ized into two main concepts of environmentally-induced or virally-
induced DNA alterations, each theory could account for some aspects of 
the various types of neoplasms but there were no unifying concepts which 
would unite the seemingly unrelatable observations. One such_perplexing 
problem was to explain how a virally transformed malignant cell could 
express an invasive nature characterized by the appearance of proteo-
lytic enzymes on the cell membrane when the viral genome did not contain 
those particular genes. Also, in the great majority of animal cancers 
which occurred spontaneously in nature, no evidence for a virus particle 
could be found. Indeed, the majority of viruses which could induce 
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malignancies were active only when paired with cells from species which 
were not their normal hosts (42). Finally, although diligent efforts 
have been made, no human malignancy is directly attributable to a virus 
(42). The most likely candidate would be the Ebstein-Barr virus which 
may only play a part in the development of Burkitt•s lymphoma (43). 
Therefore, the animal virus models of malignancy are of interest, but . 
dot not appear to be of great importance for drawing correlations to 
human lesions. 
There is no doubt that environmental agents can and do cause malig-
nant tumors (1). But the question here again was how could extremely 
small molecular weight molecules or radiation alter a normal cell 1s 
genetic complement to such an extent that the result was a malignant 
lesion. The search for normal proteins which had been mutated to rene-
gade states was pursued, but instead of finding new unique proteins 
which lacked normal regulatory checks and balances, an interesting pat-
tern began to emerge. Knox (44) categorized the levels and types of 
enzymes present in normal tissues during their embryonic development, 
and then attempted to place the various malignancies along the spectrum 
of developing enzymatic activities. He observed that undifferentiated, 
fast-growing tumors originating from the liver and from mammary gland 
have almost the same characteristic enzymatic components. Differenti-
ated tumors from liver and mammary gland differ in composition, each 
tending to resemble the enzymatically different parent tissues. He 
theorized that a prototypic composition of tumors, from whatever the 
source, appears to exist. When this composition is diluted by the 
various enzymes of normal tissues, the products are tumors of lesser 
neoplastic character which are more differentiated, slower growing, and 
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less autonomous tumors. Most importantly, he noted the prototypic com-
position of tumors is very similar but not identical to that of many 
fetal tissues in both the quantitative pattern of enzymes and the quali-
tative identities of certain isozymes. It appeared as if a fraction of 
the cell's genome was acting in the same way in immature and tumorous 
tissues but differently in adult tissues, i.e. the tumor had dediffer-
entiated. 
Fortunately, considerable evidence is accumulating in favor of 
models for gene regulation in eukaryotic cells which would support this 
dedifferentiation theory of malignancy. Experimental results which must 
be explained by a model are (45): (a) Animal structural genes are in 
general single copy sequences with an average length of about 1200 
nucleotides; (b) Thousands of diverse initiation sites for mRNA syn-
thesis are specified in differentiated cells, indicating a general regu-
lation of transcription; (c) For at least one case, the sea urchin 
gastrulat over 104 specific structural genes are in use, meaning that 
this number of initiation sites for transcripts which include structural 
gene sequences must have been activated. This finding probably pre-
cludes consideration of any regulatory system that does not involve 
specific DNA sequence recognition as a fundamental feature; (d) The 
DNA of eukaryotes displays an ordered interspersion of short repetitive 
sequences of about 300 nucleotides, and long nonrepetitive sequences 
of about 1200 nucleotides; (e) This ordered sequence arrangement pro-
bably plays some fundamental role in the life process since it has been 
preserved in quantitatively similar form in sea urchin and amphibian 
DNA even th~ugh the ancestral genomes of these organisms have been 
evolving along separate lines since the Cambrian period; (f) Lower 
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organisms such as the lambda phage have early and late functionally 
related genes which are coordinately transcribed after the appropriate 
regulation stimulation; (g) Although approximately 70% of the rabbit 
genome is composed of unique sequence DNA, only 1.8% of this DNA is 
transcribed in the multipotent cells of the rabbit blastocyst, and the 
addition of blastocyst RNA to midgestation RNA raises the percentage 
of hybridizable DNA from 1.8% to 3.2% indicating that there are differ-
ent genes being transcribed at these periods of development. The pro-
gressive restriction concept of gene expression during development is 
therefore incompatible with the experimental observations. The Britton-
Davidson model for animal gene regulation (46) predicts the above 
observations. Very briefly their model proposes functionally associated 
batteries of genes which are coordinately activated during the appro-
priate stage of differentiation. A key feature of their gene regulation 
model is that the physical basis for coordinated activation of struc-
tural genes is the presence of homologous repetitive sequence elements 
in the vicinity of the initiation sites of genes destined to be activat-
ed in concert. Each structural gene in a given battery is preceded by 
a certain repetitive sequence, the receptor sequence, which is charater-
istic for that battery. These repetitive sequences serve as recogni-
tion and binding sites for sequence-specific regulatory macromolecules 
termed activators. The term activator is chosen to indicate that the 
major type of regulator event is expected to be sequence-specific acti-
vation of otherwise repressed structural genes (positive control rather 
than repression). It is considered that nonspecific repression mediated 
by histones and possibly other chromosomal proteins prevails in all 
regions of the genome other than those whose activity is specified. By 
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definition, the diffusible activator molecules must possess the capacity 
for recognition of specific DNA sequences. Since either protein or RNA 
could serve this function, both have to be considered as possibilities. 
Additional evidence is drawn from clinical evaluation. In recent 
years several antigens usually present only in fetal tissues have also 
been found in the sera and tumor tissue of patients with gastrointesti-
nal cancer (47). The carcinoembryonic antigen, alpha-fetoprotein, fetal 
sulfoglycoprotein antigen, and the carcinoplacental alkaline phosphatase 
(Regan isoenzyme) are some of the best known. Initially carcinoembry-
onic antigen and a-fetoprotein were believed to be highly specific 
diagnostic indicators for colorectal and hepatocellular cancer, respec-
tively (48). Subsequently, carcinoembryonic antigen was shown to be 
present in other gastrointestinal and nongastrointestinal cancers. The 
initial reports of elevated serum carcinoembryonic antigen levels in 
91% to 97% of colon cancer patients raised hopes that it would serve as 
a screening test. However, recent data show that carcinoembryonic anti-
gen is increased in less than half of potentially resectable colorectal 
cancers, and that the previously reported high frequencies are found 
only in those patients with widespread metastatic cancer (49). In 
gastric cancer, carcinoembryonic antigen has been found to be abnormal 
in 73% of the patients with distant metastases. Serum a-fetoprotein, 
in addition to bei~g frequently positive in hepatocellular carcinoma, 
has been detected in the sera of some patients with gastric and non-
gastrointestinal cancer metastatic to the liver (50). 
These abbreviated examples suggest strongly the concept that cancer 
is indeed a developmental disease, that it is not necessary to invoke 
alterations in the genotype to account for the behavior of malignant 
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cells. For example, genetic information that is normally and usefully 
expressed to accomplish mammalian placentation is malignant when ex-
pressed in decendents of the embryoblast. The causes of cancer, be they 
viral, chemical, physical or spontaneous, are interpreted in this view 
as disrupting mechanisms of gene regulation and integration which 
results in a dedifferentiated cell with an enzymatic complement tending 
toward the embryo. 
Realizing the tremendous range of differentiation represented by 
the established mammary tumor lines, it was felt that studies should be 
conducted on a minimum deviation tumor, and an ascitic line. The 
R3230 AC mammary adenocarcinoma is the tumor of choice for the former. 
Hilf et !l· (51) originally described this transplantable rat mammary 
carcinoma of spontaneous origin which does not depend upon estrogen or 
prolactin for growth, but which would respond to these hormones with 
distinct alterations in enzymatic activities. Totally specific to the 
Fisher rat strain, this adenocarcinoma has endogenous levels of a-LA 
and caseins that can be readily measured. Turkington and Riddle (52) 
attempted to study how mechanisms which control hormone-dependent gene-
tic expression might be altered in malignant cells. They used explants 
of normal midpregnant or lactating mammary gland and explants of the 
R3230 AC carcinoma grown in ovariectomized rats which, after two weeks 
of tumor growth, were given one mg of estradiol-17S every three days 
for two weeks prior to tumor removal or oil injections for control 
animals. Casein synthesis was measured by allowing the explants to 
incorporate 32po43- or 14c-amino-acids for four hours, isolating them by 
rennin and calcium precipitation, and measuring the labeling using poly-
acrylamide gel electrophoresis patterns. Explants from normal lactating 
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glands produced gel patterns of labeled caseins which were qualita-
tively identical to the estrogen treated R3230 AC gel patterns except 
that the tumor incorporated only ten perGent as much 32Po43-. Control 
tumors which received no estrogen injections in the host rat nor in 
the organ culture showed significantJy reduced 32P-casein profiles. 
Enzymatic activities of the two proteins of lactose synthetase, galac-
tosyltransferase and a-lactalbumin, were detectable in homogenates of 
tumors carried in ovariectomized rats, and estradiol stimulation en• 
hanced both activities. Organ culture experiments done in vitro with 
24 hour incubation with estrogen gave similar results to the in vivo 
experiments. Values for galactosyltransferase activity of the R3230 AC 
tissue in ovariectomized rats were 6.8% of the lactating rat mammary 
gland and was raised to 11.6% with estrogen treatment. Similarly, a-LA 
levels were 2.6% without estrogen and were raised to 23.9% after estro-
gen stimulation and reflected an increased rate of amino acid incorpo-
ration into a-LA. · Estradiol treatment does not affect a general in-
crease in synthesis of cytoplasmic proteins in the carcinoma, however. 
Explants from midpregnant Fisher rat mammary glands incubated for 48 
hours in estrogen alone, or in various combinations with insulin, hydro-
cortisone, or prolactin did not result in a stimulation of casein syn-
thesis or of lactose synthetase activity above the corresponding control 
value. These observations led them to propose that, since the milk 
proteins in normal mammary gland tissue were not increased by estrogen 
alone but were stimulated in the R3230 AC, these malignant cells had 
acquired a new hormonal responsiveness as a consequence of their neo-
plastic transformation. In a later paper Turkington and Riddle (53) 
also demonstrated that a combination of insulin, hydrocortisone and 
prolactin could double the level of galactosyltransferase and could 
increase one and one-third times the level of a-LA in explants from 
normal virgin rats grown for 48 hours in the hormones. However, the 
methods they used to assay galactosyltransferase and a-LA utilized 
incorporation of radioactive galactose from UDP-[u-14c] galactose 
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into lactose and is subject to high backgrounds produced by hydrolysis 
of UDP-galactose to galactose. In addition, the levels they reported 
are at the very limit of detection of the incorporation assays. A 
recent paper by McGuire et ~· (54) further confounds the situation by 
reporting that the R3230 AC tumor is markedly deficient in estrogen 
receptor content when compared to hormone-dependent tumors or to normal 
estrogen target tissues. 
Estrogen, which circulates in the blood partially bound to serum 
proteins, is a very lipid soluble steroid hormone which is able to pass 
through essentially all cell plasma membranes, and is in very rapid 
equilbrium between the serum and the cytoplasm in cells which do not 
contain the cytoplasmic estrogen receptor. Found only in tissues which 
are estrogen sensitive such as the uterus, vagina, or anterior pitui-
tary, this receptor is a large, very elongated prolate ellipsoid of 
about 227,000 molecular weight which is 18 times as long as it is wide 
and is composed of two very similar subunits, both of which bind two 
steroid molecules very tightly (55). Binding of estrogen to the recep-
tor enables both to pass through the nuclear membrane and attach even-
tually to specific receptor sites on the chromosomes, where it triggers 
transcription of selected regions of DNA. This recognition of chromo-
somal regions is directed by .the acidic chromatin material rather than 
the particular DNA base sequence or histones (56). 
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As is well known, some mammary tumors in both humans and animals 
depend upon estrogen for continued growth, while others are relatively 
autonomous. Attempts have been made to link the difference between 
them with the lack of estrogen receptors in autonomous tumors. McGuire 
and Julian (57) examined unequivocally proven hormone-dependent and 
independent mammary tumors induced by dimethylbenzanthracene for the 
presence of estrogen-receptor in their cytoplasm. They found that the 
4S high affinity estradiol-binding moiety was found only in the unequi-
vocally hormone-dependent tumors. They also investigated the R3230 AC 
and reported that, although the tumor does contain high affinity estra-
diol binding sites in the cytosol, the concentration of these sites is 
only 10% compared to the dimethylbenzanthracene induced estrogen depen-
dent tumors, or only 5% compared to normal lactating mammary tissue. It 
has been rather conclusively shown that the levels of a-LA and galacto-
syltransferase in the R3230 AC are both sensitive to estrogen admini-
stration in vivo (58) and that the tumor fails to regress following 
ovariectomy (54). This paradox of apparent milk protein sensitivity to 
estrogen, which would require estrogen receptors, and proven autonomous 
growth, which would theoretically necessitate the absence of estrogen 
receptors, was explained by a new theory. Keeping in mind that Turking-
ton (9) reported that estradiol ~vitro had no influence on stimulation 
or inhibition of R3230 AC cells entering the DNA synthetic phase, 
McGuire et ~· (59) cites data suggesting that the effects of estrogen 
on growth of mammary carcinomas are largely indirect and that the estro-
gen-dependent tumors are in fact prolactin-dependent. Measurement of 
prolactin receptor levels in normal lactating gland indicated 3.800 
high affinity receptor sites per cell and 2,600 sites per cell for the 
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R3230 AC tumor. This significant level of prolactin receptors appears 
to conflict with McGuire's theory of hormone-independent growth of the 
R3230 AC. The biochemical lesions leading to independent growth must 
lie distal to the prolactin binding step or alternatively in a function 
regulated by the estrogen receptore McGuire feels that there is not 
necessarily a causal relationship between the relative lack of estrogen 
receptor and the hormone-independent growth of a tumor. Rather the 
estrogen receptor may be a useful cell marker for hormone dependence, 
its absence being a signal that malignant transformation of normal 
mammary cells has resulted in the deletion of certain components of the 
normal hormonal regulatory system (59). 
Radioimmunoassays 
The goals for measurement of a substance are to have the greatest 
sensitivity with the highest precision, accuracy, and specificity possi-
ble. The techniques must be quick and easy to perform and require rela-
tively inexpensive equipment. For many substances, the radioimmunoassay 
technique is the best choice. Since Yalow and Berson (60) introduced 
the radioimrnunologic method in 1959 for the determination of plasma 
insulin, it has found applications for many different situations, espe-
cially for proteins which do not have a known enzymatic function, such 
as caseins ore-lactoglobulin. Even for proteins such as a~LA, which 
have well characterized enzymatic action, there may be great difficulty 
measuring them by the conventional methods in certain tissues. a-LA 
participates in lactose formation by lowering the apparent Km of glucose 
from 1.4 M to 4 mM so that it becomes a good substrate for galactosyl-
transferase which combines the substrates UDP-galactose and glucose to 
25 
form the disaccharide lactose (3). The proposed enzymatic mechanism is 
presented in Figure 1. Fitzgerald et ~· (61) developed both a spectro-
photometric assay for a-LA, which has a realistic limit of detection of 
two to three ~g of a-LA/ml, and a radioactive incorporation assay which 
has a realistic limit of detection of 0.5 ~g of a-LA/ml. The incorpora-
tion assay utilizes UDP-[u-14c] galactose and saturating levels of glu-
cose, Mn++, and galactosyltransferase forming labeled lactose. However, 
many tissues such as lactating mammary gland, kidney, liver, and espe~ 
cially most mammary tumors contain high levels of an enzymatic system 
which can cleave a variety of nucleotides with the liberation of the 
respective nucleoside-5'-monophosphates and sugar-phosphates (62) which 
are then hydrolyzed to the free sugar by broad spectrum phosphatases. 
Although the pyrophosphatase is membrane associated, it is easily solu-
bilized by homogenization. Geren and Ebner (63) demonstrated that the 
nucleotide pyrophosphatase can utilize UDP-galactose 100 times more 
rapidly than the galactosyltransferase. Even using folic acid or 
5'-AMP as inhibitors of the hydrolase system, free galactose production 
can often surpass the production of labeled lactose, resulting in back-
grounds for samples that are 70 to 80 percent of the total observed 
radioactivity in the assay. 
The ideal solution to the problem is to utilize an assay which 
would recognize the unique three-dimensional conformation of a-LA, 
and this is met by a RIA. In 1974 Beck and Tucker (64) developed a 
RIA for bovine a-LA which was capable of detecting 25 to 700 ng of 
a-LA/ml and showed no displacement with one ~g of casein, bovine serum 
albumin or s-lactoglobulin. Two human a-LA RIAs have been reported 
which both have limits of detection around the one to four ng of a-LA/ml 
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range. Rose and McGrath (65) examined the cross-reactivity of their 
rabbit anti-human a-LA antibody with a-LA from six animal species by 
competitive binding in the RIA. None of the a-LAs cross-reacted signi-
ficantly in the RIA based on the amount of a-LA from the different 
species required to inhibit 50% of the human a-LA binding (I5o). Only 
0.24 ng of human a-LA were required as compared with bovine 5.2 ~g, 
rat 9.0 ~g, dog 20 ~g, and goat 45 ~g. Gerbil (25 ~g) and pig ( 50 ~g) 
a-LAs could only achieve 23% displacement, and lysozyme showed no dis-
placement even at 100,000 times molar excess. They isolated a human 
cell line, designated MCF-7, derived from a pleural effusion of a 
patient with metastatic breast adenocarcinoma which contains the estra-
diol binding protein (66). Analysis for a-LA by RIA showed that MCF-7 
had 207 ng of a-LA/mg of protein but a-LA could not be induced by in-
cubation of the cell line in media containing 5% calf serum with insulin, 
hydrocortisone, and prolactin for up to 16 days. Kleinberg (67) used 
a RIA to determine the levels of a-LA in sera from patients with various 
diseases. He reported finding a-LA in the sera of normal men and non-
lactating females at levels greater than one ng of a-LA/ml in 69% of 
the males and 46% of the females. The mean of the measurable male 
values was 5.8 ng of a-LA/ml and the females had a mean of 6.42 ng of 
a-LA/ml. a-LA was detectable in all lactating sera samples with a mean 
of 188 ng of a-LA/ml and individual values ranging from 45 to 640 ng of 
a-LA/ml. a-LA was measured in a group of 35 patients with nonpuerperal· 
galactorrhea. Five patients had undetectable levels and the remaining 
30 had a mean level of 55 ng of a-LA/ml, the range being from 2 to 400 
ng of a-LA/ml. In a group of 44 patients with metastatic breast carci-
noma, five had levels of serum a-LA from one to 12 ng of a-LA/ml. Pro-
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lactin serum values were also measured for all the groups and the men 
had a mean level of 7.13 ng prolactin/ml, normal females 10.9 ng pro-
lactin/ml, nursing mothers 69.3 ng prolactin/ml, galactorrhea 63.4 
ng prolactin/ml, and those with breast cancer had 12.4 ng prolactin/ml. 
When fragments from 19 breast cancers were grown for three days in 
medium 199 with added insulin and hydrocortisone, only four of the 
tumors had detectable a-LA concentrations ranging from 0.9 to 3.3 ng 
of a-LA/ml in their bathing media. Addition of prolactin did not in-
crease a-LA in the media from any of the 19 tumors. 
The class of proteins called caseins comprises about 80% of the 
total milk protein, and are, for the most part, neatly packaged for 
secretion from the lactating cell in the casein micelle. Caseins are 
characterized by ester-linked phosphate to specific serine or threonine 
residues, high proline contents, few or no cysteine residues, and iow 
solubility at pH 4 - 5. However, a clear-cut definition based on these 
parameters is not possible since some caseins are devoid of phosphate, 
contain disulfide bonds, have variable proline contents, are soluble 
at pH 4.5, and are not precipitated at minimum ammonium sulfate con-
centrations required to precipitate most caseins (68). The caseins of 
bovine milk have been grouped into four main classes, the as-caseins, 
s-caseins, y-caseins, and K-caseins, and their amino acid sequences are 
known (69). All are characterized by a high content of proline resi-
dues randomly distributed throughout the molecules, thus preventing any 
effective formation of secondary structure such as a-helices. The 
molecules exhibit zones of high polarity with closely located ionizable 
groups and other zones that are strongly hydrophobic. In the presence 
of calcium and phosphate, the caseins have a strong tendency to form 
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micelles in which the K-caseins play the key role by stabilizing the 
other caseins from precipitation. The casein micelle is composed of 
63% as-casein, 14% K-casein, 19% s-casein, and 3% y-casein, with 2.9 gm 
% ca++, 0.1 gm% Mg++, 0.8 gm% organic phosphorous, and 1.4 gm% in-
organic phosphorous. The discovery of genetic polymorphism in bovine 
a5-casein lead to the discovery of four variants whose synthesis is 
controlled by four allelic autosomal genes with no dominance (70). It 
is possible that a very large polypeptide chain is first synthesized 
and then split by limited selective proteolytic cleavage into the indi-
vidual casein molecules. Certainly, the evidence seems strong that 
y-casein and the R, T, and TS fragments are derived from proteolysis of 
8-casein (71). K-casein differs markedly from as- and s-caseins in 
that it contains bound carbohydrate and is cross-linked by disulfide 
groups. One of its outstanding characteristics is a phenylalanine-
methionine peptide linkage which is especially sensitive to attack by 
rennin and other proteases which liberates a glycomacropeptide of 8,000 
molecular weight containing the carbohydrate moiety. This hydrolysis 
renders the remainder of the molecule (para-K-casein) precipitable by 
calcium and destroys the ability of K-casein to stabilize the other 
caseins against calcium precipitation (72). 
Since caseins are under the hormonal control or prolactin, some 
investigators have chosen to use them as marker proteins for mammary 
gland function. Hendrich and Franchimont (73) developed a double anti-
body RIA using rabbit antibodies for human II-caseins and K-caseins 
which were isolated by precipitation at low pH, and DEAE ion-exchange 
chromatography. The caseins were iodinated by the chloramin-T method. 
The resulting iodinated traces were unstable after eight days and tests 
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indicated that the labeled II- and K-caseins existed in polymeric forms. 
~urther analysis has indicated that human casein contains a minimum of 
six electrophoretically distinguishable caseins, none of which corre-
spond to bovine as-casein's migration. Rather, all fall in a narrow 
range of mobility between bovine y- and K-caseins. Amino acid analyses 
of fractions I-VI are nearly identical with variations seen only in 
phosphorous content, leading to the view that they represent a single 
protein with varying levels of phosphorylation. Human K-caseins are 
similar to bovine K-casein (74). In their RIA the smallest detectable 
amount, defined as the lowest concentration of unlabeled antigen, which 
when added to a solution containing only labeled antigen and antibody 
results in significant change in the response variable, was 100 ng/ml 
With a precision of 8%. Also sera from different patients were ~xamined. 
Casein was found in the sera of all eleven lactating women with a range 
of 300 to 2,800 ng casein/ml and an average of 1,070 ng casein/ml. No 
case was found in the sera of 27 pregnant women. Five percent of 74 
normal men and 3% of 36 normal women had levels greater than 10 ng 
casein/ml. Only one of seven patients with benign breast lesion had 
detectable concentration of casein: 350 ng casein/ml of serum. Eight 
of eleven patients, or 72%, with breast cancer prior to any treatment 
had detectable levels in their serum with a mean value of 283 ± 105 ng/ml. 
Forty-one patients with breast cancer at Stage I were treated surgically 
by simple mastectomy with the removal of regional lymph nodes and post-
operatively by irradiation and showed no clinical signs of metastases. 
Seventeen of the forty-one, or 41%, had serum caseins with a mean of 
588 ± 160 ng casein/ml. Sixty-one patients with breast cancer had been 
treated surgically and irradiated post-operatively, but showed evidence 
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of metastases in the axillary lymph nodes and therefore belonged in 
Stage II. Thirty-four of the sixty-one, or 50%; had elevated serum 
casein levels with a mean value of 781 ± 200 ng casein/ml. Casein was 
found in large quantities in the serum of twenty-one of twenty-six 
patients presenting with a local recurrence or with distant metastases 
from their tumor. In these patients, the levels were usually markedly 
elevated and the mean value of positive cases was 1,235 ± 360 ng 
casein/ml. In seven of fourteen patients, or 50%, with gastrointestinal 
neoplasms, casein was found at levels between 120 and 660 ng casein/ml 
with a mean value of 235 ± 60 ng casein/ml. Seven out of seven patients 
with lung cancer had elevated casein with a mean value of 342 ± 57 ng 
casein/ml. Hendrich and Franchimont (73) remark that they have been 
unable to establish any correlation between the presence of serum 
casein and the histological nature of the tumor; caseih could be found 
with equal frequency in solid carcinomas in scirrhous cancers, in adeno-
carcinomas, and in ductal carcinomas. They evoke ectopic exocrine 
secretion to explain the appearance of caseins in 50% of the gastro-
intestinal cancers and in 100% of the lung cancer. 
Lactoferrin, another protein present in milk, has been studied in 
the serum of patients with breast cancer (75). Unfortunately this sub-
stance is present in sperm and in neutrophile leukocytes and can leak 
into the serum thus causing false high levels. This undesirable aspect 
has eliminated the specificity needed for serum analysis. 
Immunofluorescence andy-globulin Receptors 
Another method of detecting a-LA in normal and malignant cells is 
by the indirect immunofluorescent staining technique of Coons (76). 
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Briefly, this involves incubating a 4 to 6 micron thin section of a 
tissue with a solution of immune serum containing antibody to the 
desired molecule, washing unbound y-globulins off, then flooding the 
section with a solution containing fluorescein labeled antibodies 
directed against the original immune y-globulins. This sandwich tech-
nique provides a significant increase in specific fluorescence over 
the direct labeling technique. Proper controls for this study are, 
however, absolutely imperative. They include substituting a non-immune 
serum in place of the immune serum to detect any nonspecific species 
cross-reactivity or tissue binding of they-globulin, and omission of 
the immune serum to determine any direct binding by the second fluore-
scent y-globulin. Bussolati et ~· {77) have investigated several 
human mammary diseases by immunofluorescent methods. Preparing a 
human casein fraction by merely acid precipitating milk, he prepared 
rabbit antibodies. Cryostat sections from fresh-frozen tissues were 
fixed in 95% alcohol for 20 minutes at room temperature and paraffin 
sections from formalin fixed tissue blocks were de-paraffinized and 
returned to the water phase. His results indicated most neoplastic 
cells in medullary and Grade III poorly differentiated carcinomas 
were negative for casein by immunofluorescence. A thin rim of speci-
fic fluorescence at the periphery of the cytoplasm could be seen in 
some areas of intraductal, in papillary, in mucinous carcinomas, and 
in some Grade II moderately differentiated infiltrating carcinomas. 
In intraductal carcinomas with cribriform patterns, casein could 
be seen lining and sometimes filling intercellular spaces. In Grade I 
well differentiated carcinomas, casein was present and localized at 
the inner border of the gland-like structures. In the two cases 
examined, cells metastatic to the lymph nodes were also positive, 
arranged in small clusters in the peripheral sinus. The two cases 
of adenocarcinoma of the rectum gave negative results. 
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Examination of mammary and extramammary Paget's disease for casein 
added weight to the opinion that these clear cells are the result of 
intraepidermal migration of neoplastic cells from an underlying breast 
carcinoma, rather than representing a lesion of the nipple epidermis 
or originating from degenerating melanocytes (78). In 16 cases of 
Paget's disease of the nipple with underlying ductai carcinomas, intense 
positive staining was observed in ten cases, while in four cases the 
staining was definite but weak. In four cases of extramammary Paget's 
disease of the vulva and anogenital area, one was intense and three 
were moderate to weak. Control cases of basal cell carcinoma, melano-
carcinoma, and intradermal benign nevus gave negative results, but 
quite significantly the sebaceous and sweat glands in all the tissues 
gave positive staining. 
Using antibodies to bovine $-lactoglobulin, Twarog and Larson (79) 
examined bovine mammary gland cells in prolonged organ culture and 
found that they lost the ability to synthesize $-lactoglobulin with 
time, but that all the secretory epithelial cells showed positive 
fluorescence for $-lactoglobulin. 
In order to determine whether the synthesis of a-LA and casein 
occurred together within all mammary epithelial cells or within sepa-
rate cell types, Turkington (80) prepared rabbit antisera to mouse 
casein component three and Fisher rat a-LA which cross-reacted with 
mouse a-LA in a non-identity reaction. His results, using a short 
ethanol-ether fixation on ten day lactating C3H/HcJ mice, indicated 
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virtually every alveolar cell was positive for both a-LA and casein. 
Unfortunately, he did not run the control slide with normal rabbit 
serum substituting for immune rabbit serum followed by reaction with 
fluorescent goat antirabbit y-globulin. As will be shown, rat mammary 
gland fixed for short periods binds y-globulins, so his conclusions 
are not unequivocal. 
A very recent report by Kember et ~· (81) demonstrates that non-
fixed tissue sections from colostrum-forming bovine mammary gland 
possess highly selective binding activity for secretory immunoglobulin G 
(IgGs). This activity is not found in the bovine post colostrum-forming 
lactating gland. Inhibition assays showed that IgGs binding was blocked 
by both Fab/c and isolated H-chains but not by bivalent F(ab)2, Fab, and 
Fe fragments suggesting that the binding region is located within the 
heavy chains. In addition, IgG preparations from human, sheep, and 
rabbit were all equally effective at inhibiting bovine IgGs binding, 
but no inhibition was obtained with nonmarrmalian turtle and chicken IgG. 
These observations are consistent wtih the known classes of immuno-
globulins in mammary secretions, and methods of transmission of immunity 
from mother to young. Mammals can be classified into at least three 
groups on the basis of their mode of transmitting immunoglobulins (82). 
Humans, monkeys, and rabbits (Group I) acquire all of their maternal 
immunoglobulins in utero and enter the world with a serum level of IgG 
equal to that of their mothers. Conversely, ungulates such as cows, 
horses, pigs, and goats (Group III) derive all maternal immunoglobulins 
from colostrum during the first few hours after birth. Rats, mice, 
cats, and dogs (Group II) acquire maternal immunoglobulins both in utero 
and by way of the colostrum. Only IgG molecules are transmitted by 
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animals that receive in utero transfer of immunogl_obulins. Species 
that transmit immunoglobulins exclusively in utero, Group I, produce 
colostrum that is predominately composed of IgA while those that trans-
mit immunoglobulins exclusively via the colostrum, Group III, have a 
colostrum composed predominately of IgG and some IgM and IgA. Mammals 
in Group II demonstrate various intermediate compositions with high 
levels of both IgG and IgA but low IgM. It is interesting to note 
that Group I animals such as man have no immunoglobulin absorption by 
the gut of the newborn. The proteolytically resistant IgA molecules 
are thought to provide essential resistance to intestinal bacterial or 
viral infections for the newborn. The Group III mammals have extensive 
absorption by the newbornis gut for up to 48 hours with some species 
showing selective absorption of I9G. Rats and mice from Group II have 
moderate rates of gut absorption and are selective for I9G but absorp-
tion continues for 19 days post parturition. These observations may 
indicate which immunoglobulin subclasses should or should not bind to 
colostrum or mature lactating mammary epithelial cells. 
CHAPTER III 
DEVELOPMENT OF RADIOIMMUNOASSAYS 
Isolation of Rat and Human a-Lactalbumin 
Materials and Reagents 
Rat milk was obtained from lactating Fisher rats throughout their 
lactational period by gentle aspiration of the nipples after anesthe-
tization by intramuscular injection of pentabarbital (0.1 ml/150 gm) 
and induction of milk release with intramuscular injection of oxytoycin 
(0.5 ml/150 gm). Human breast milk was a gift from the Oklahoma Medi-
cal Research Foundation. Pyruvate kinase (Type I from rabbit muscle 
in ammonium sulfate suspension containing lactic dehydrogenase), glycine, 
phosphoenolypyruvate, NADH, Tris, bovine serum albumin, and bovine 
y-globulin fraction II were purchased from Sigma Chemical Company. 
Acrylamide gel electrophoresis reagents and Bio-Gel P were purchased 
from Bio-Rad. DEAE-cellulose was purchased from Whatman. Small bore 
4,000 to 6,000 molecular weight cutoff dialysis tybing was purchased 
from Spectrapore. 
Methods 
Spectrophotometric Assay for a-Lactalbumin. a-LA was assayed in 
the presence of saturating amounts of galactosyltransferase, Mn++, 
glucose, and UDP-galactose according to the method of Fitzgerald et ~-
36 
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(61). Enzymatic activity was assayed spectrophotometrically at 340 nm 
by coupling UDP formation to NADH oxidation by adding phosphoenolpyru-
vate and pyruvate kinase. 
Gel Filtration and Ion Exchange Chromatography. Molecular weight 
gel filtration was performed at 4° C on samples dissolved in 100 mM 
KCl, 20 mM Tris, pH 7.4 which was the column buffer. A 5 em x 100 em 
column was packed by the slurry technique with P-150, 100 to 200 mesh, 
which had been swollen, degassed and had the fines removed according 
to the Bio-Rad manual (83). Using a pressure head of 30 em, approxi-
mately 400 mg of protein in a volume of 15 ml were applied and washed 
into the column. Five ml fractions were collected with a seven s/drop 
flow rate. Dextran blue was never mixed with the samples to eliminate 
nonspecific binding to the a-LA. DEAE-32 was generated by the procedure 
recommended by the Whatman manual (84), and packed in a 2.5 em x 25 em 
column and washed with 20 mM T~is, pH of 7.4 until the effluent had a 
conductivity of less than one m mho. Samples to be applied were dialy-
zed in 6,000 molecular weight cutoff dialysis tubing against 20 mM Tris, 
pH 7.4 until its conductivity was also less than one m mho. After the 
sample was washed into the column at 4° C, a two liter total volumn 
linear gradient of 0 to 300 mM KCl, 20 mM Tris, pH 7.4 was passed 
through the column at a flow rate of six seconds per drop and five ml 
fractions were collected. 
Acrylamide Gel Electrophoresis. Standard discontinuous gels, 
10 em x 0.5 em, at pH 9.5 were prepared according to the method of 
Davis (85). Sample solutions were dialyzed overnight against the upper 
gel buffer, 5 ~1 of 0.005% bromophenol blue in water was added as a 
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tracking dye and solid sucrose added until the protein solution was 
more dense than the upper reservoir buffer. After layering the sample 
onto the stacking gel, the gels were run at 7 m amps/gel at room tem-
perature until the tracking dye was near the end of the gel, at which 
time they were removed from the tubes. The tracking dye was marked 
by a wire and the gels were placed in 7% acetic acid (v/v) and 0.007% 
(w/v) Coomassie Blue overnight to stain the protein bands. Destaining 
was by d1ffusion against 7% acetic acid. Two sodium dodecyl sulfate 
systems were utilized. The standard non-discontinuous system of Weber 
and Osborn (86) was followed exactly with a 30 minute pre-electro-
phoresis step. The Neville (87), or discontinuous gel system, was not 
modified and sample preparation and current levels for both systems 
were as described in the respective papers. After marking the dye 
front, sodium dodecyl sulfate was removed from the gels by extraction 
in 40% methanol and 7% acetic acid (v/v), and stained and destained 
as for the discontinuous gels. Final gel patterns were scanned at 
560 nm using the Gilford Model 240 spectrophotometer with the linear 
transport unit. 
Acrylamide gels were sliced with the Bio-Rad gel slicer Model 190 
into 2 mm thick sections. Protein was extracted from the gel slices 
by macerating the gel in 0.5 ml of 0.1 M KCl, 20 mM Tris, pH 7.4 
followed by freezing and thawing. 
Results 
McFarland (88) attempted to isolate a-LA from Fisher rat milk using 
the procedure of Schmidt et ~· (89). Purity of the final material was 
determined by gel electrophoresis on short (5o5 em x 0.5 em) 7% acryla-
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mide gels prepared by the Davis procedure but cast without the stacking 
gel. Detection of protein by staining with Aniline Blue Black revealed 
at least three major bands, two of which had very similar migration 
coefficients of about 0.5 and one band which had a low migration co-
efficient of about 0.1. Spectrophotometric analysis of macerated and 
extracted gel slices indicated that both the fast and slow migrating 
bands contained a-LA activity. This observation led to the proposal 
that rat a-LA existed in two forms. However, the material was not ana-
lyzed by sodium dodecyl sulfate gel electrophoresis. 
An attempt was made to reproduce McFarland•s observations using the 
same isolation procedure. The final material was analyzed by discon-
tinuous gel electrophoresis according to the procedure of Davis {85) on 
long {10 em x 0.5 em) 7% acrylamide gels at pH 9.5. Detection of 
protein by staining with the more sensitive Coomassie Blue produced 
the gel profile shown in Figure 2. Spectrophotometric analysis of 
macerated and extracted gel slices indicated that only one protein band 
contained a-LA. Sodium dodecyl sulfate gel electrophoresis of the 
material isolated by the Schmidt (89) procedure indicated the molecular 
weights of the two major protein bands were about 20,000 and 60,000. 
An attempt was made to separate the a.-LA from the higher molecular 
weight contaminants by applying the sample at room temperature to a 
100 em x 1 em column of P-100, 50 to 100 mesh, equilibrated and eluted 
with 0.1 M KCl, 20 mM Tris, pH 7.4. One ml fractions were collected, 
and the protein profile established by absorbance at 280 nm. Fractions 
were assayed for a-LA by the spectrophotometric procedure. As shown in 
Figure 3, the a-LA activity was effectively resolved from the higher 
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Discontinuous Gel Electrophoresis of Rat a.-Lactalbumin .Purified by the McFarland Procedure 
Rat a.-LA purifi,ed by the McFarland procedure .(88) was applied to 7.5 percent, lO em x 0.5 em discontinuous polyacrylamide gels at pH 9.5s stained, and scanned. at 560 nm. Gels were cut into 2 mm slices, macerated, and extracted with 0.5 ml of 0.1 M KCl, 20 mM Tris, pH 7.4 by repeated freezing and thawing. The extracted solutions were assayed for a.-LA by the spectrophotometric method at 340 nm (Methods). · 
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Figure 3. Elution Profile of Whey Proteins from Rat Milk on 
Bio-Gel P-100 
. The whey fraction of rat milk was prepared by fractionation 
at 40% and 80% saturation of ammonium sulfate and centri-
fugation at 100,000 x g for one hour, and was applied to 
a 100 em x 1 em column of P-100 equilibrated and eluted 
with 0.1 M KCl, 20 mM Tris, pH 7.4. One ml fractions were 
collected and the protein profile determined by absorb~· 
ance at 280 nm. Fractions were assayed for a-LA by the 




















An attempt was made to isolate human a-LA based on the experience 
gained from the isolation of rat a-LA. The final procedure, which was 
performed at 4° C was as follows. Human Negro breast milk was received 
frozen and was slowly thawed. The milk was centrifuged at 15,000 x g 
for 30 minutes i~ a RC-28 Sorvall centrifuge using the SS-34 head. The 
cream was removed by filtering the centrifuged solution through Whatman 
Shark Skin filter paper. The skimmed milk was centrifuged at 100,000 
x g for one hour in a Beckman L5-65 ultracentrifuge using the SW27 head 
to sediment the casein micelles. The supernatant solution was made 40% 
(0.226 g/ml) saturated with ammonium sulfate and centrifuged at 30,000 
x g for 30 minutes in the RC-28 centrifuge with the SS-34 head. The 
supernatant solution was made 80% (0.516 g/ml) saturated with ammonium 
sulfate and centrifuged as before. The pellet was resuspended with 
0.1 M KCl, 20 mM Tris, pH 7.4 at a protein level of 30 mg/ml. Approxi-
mately 0.5 grams of protein (20 ml) was applied to a 5 em x 100 em col~ 
umn of P-150, 100 to 200 mesh, equilibrated and eluted with 0.1 M KCl, 
20 mM Tris, pH 7.4. A pressure head of 30 em produced a 7 s/drop flow 
rate and 5 ml fractions were collected. The protein profile was deter-
mined by absorbance at 280 nm and a-LA activity was located by the spec-
trophotometric assay. As shown in Figure 4, the a-LA activity was 
cleanly separated from the higher molecular weight proteins. Fractions 
110 to 140 were pooled and dialyzed in the 6,000 molecular weight cut-
off dialysis tubing against 20 mM Tris, pH 7.4 until the sample's con-
ductivity was identical to the conductivity of 20 mM Tris, pH 7.4. The 
sample was then applied on a 2.5 em x 25 em column of DEAE-32 cellulose 
equilibrated with 20 mM Tris, pH 7.4. The column was washed with 100 ml 
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The whey fraction of human milk was prepared by fractionation at 40% 
and 80% saturation of ammonium sulfate and centrifugation at 























of P-150 equilbrated and eluted with 0.1 M KCl, 20 mM Tris, pH 7.4. 
Five ml fractions were collected and the protein profile determined 
by absorbance at 280 nm. Fractions were assayed for e~.-LA by the 
spectrophotometric method at 340 nm (Methods). 
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0 to 300 mM KCl, 20 mM Tris, pH 7.4 was passed through the column at 
a flow rate of 6 s/drop. Three ml fractions were collected. The pro-
tein profile and a-LA activity were determined as described before. As 
shown in Figure 5, the a-LA activity was sharply eluted and coincided 
with the major protein peak. A small contaminant was resolved from the 
a-LA peak. Fractions 90 to 100 were pooled, extensively dialyzed in 
6,000 molecular weight cutoff tubing against deionized water, and lyopho-
lyzed for storage at -20° C. 
Rat a-LA was isolated by C. Brown (90) using the identical proce-
dure, except that the a-LA peak from the DEAE-32 column was reapplied to 
the P-150 column for an additional purification step. 
The human a-LA was analyzed by the Davis (85) discontinuous gel 
system and the Weber and Osborn (86) sodium dodecyl sulfate gel system. 
As shown in Figure 6, no contamination was detectable in the gels of 
either system even when 100 ~g of protein were applied to the gels. 
Generation of Anti-a-Lactalbumin Serum 
Materials and Reagents 
The rat and human a-LA samples purified above were used as anti-
gen sources. Freund's complete and incomplete adjuvants and agar were 
from Difco. a-LAs from various species were prepared by Dr. D. Schmidt 
except for bovine a-LA which was from Sigma. Chemicals for immuno-
electrophoresis and instruments were from Gelman. Balanced salt sol.u-
tion was 0.14 M NaCl, 4 mM KCl, 0.5 mM Na2HP04, 0.17 mM NaH2P04 at 
pH 7.2. The Polytron Model P-10 homogenizer was from Brinkman. 
Methods 
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Figure 5. Elution Profile of Human a-Lacialbumin from P-150 Column 
on DEAE-32 Cellulose 
The_ pooled a-LA fraction from P~l50 column was dialyzed-extensively 
· against 20 mM Tris, pH 7.4 and applied to a 25 em x 2.5 em column 
of DEAE-32 equilibrated in 20 mM Tris, pH 7.~. The column was 
washed with 100 ml of 20 mM Tri s, pH 7. 4 and a two 1 iter tota 1 
volumn linear gradient of 0 to 300 mM KCl, 20m~ Tris, pH 7.4 
was pa~sed through the column and 3 ml fractions were collected. 
Protein profile was determined by absorbance at 280 nm. Frac-
tions were assayed fo_r a-LA by the spectrophotometric method at 

























_j__ __ L __ _L_ I _L 
0 1 2 3 4 5 6 7 8 9 10 
Migration (em) 
Figure 6. Acrylamide Gel Electrophoresis of Purified Human a-Lact-
albumin 
Human a-LA (100 llg) from the DEAE-32 column was applied to 10 em x 
0.5 em 9els prepared by (A) Davis (85) procedure, and (B) Weber and 
Osborn {86) procedure, stained with Coomassie Blue, and scanned at 
560 nm (Methods). 
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Adult white rabbits were injected in two places subcutaneously on 
the back with a total of 4 mg of human or rat a-LA dissolved in 0.5 ml 
of balanced salt solution and mixed with 6 ml of Freund 1s complete ad-
juvant and then homogenized with a Polytron set at 5.4 for two minutes 
at 4° C. After two weeks, 4 mg more of a-LA in 4 ml of Freund•s in-
complete adjuvant were prepared as before and injected subcutaneously 
on the back. Blood was drawn from the ear vein or by heart puncture and 
immediately centrifuged at 5,000 x g for 20 minutes at room temperature 
to separate the serum. Immunoelectrophoresis was done according to the 
method in the Gelman manual (91). Double diffusion plates were 1% agar 
in 0.1 M KCl, 20 mM Tris, pH 7.0 and were developed at 4° C, 25° C, or 
37° C, and then photographed. All antigen solutions were 0.5 mg/ml in 
balanced salt solution and antisera were undiluted. 
Results 
Sera collected three weeks after injection of rat or human a-LA 
showed weak precipitin lines in double diffusion tests against the anti-
gens. Five weeks after injection, strong bands were seen against rat 
or human a-LA. Cross-reactivity to a-LA from other species was investi-
gated using the double diffusion technique with antisera drawn at vari-
ous times after injection of a-LA. As shown in Figure 7, antirat a-LA 
sera consistently had only weak cross-reactivity to human a-LA which 
demonstrated non-identity. However, antihuman a-LA sera had cross-
reactivity to rat, bovine, goat, and pig a-LA five weeks after injection 
which was not detectable three weeks after injection. This observation 
indicates that human a-LA is capable of eliciting a time-dependent 
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Figure i. Cross-Reactivity of Anti-a-Lactalbumin Sera 
Rabbits were injected subcutaneously with a-LA in Freund•s adju-
vant and sera were collected after various times of immuni-zation and tested for cross-reactivity to a-LA from other species in double diffusion plates of 1% agar, 0. 1 M KCl, 
20 mM Tris, pH 7 at 25° C. Wells contained (1) human a-LA, (2) rat a-LA, (3) bovine a-LA, (4) pig a-LA, (5) goat a-LA, and (6) bovine serum albumin, all at 0.5 mg/ml. Panel (A) and (B) contained antihuman a-LA serum drawn at three weeks 
and five weeks respectively in the center wells. Panel (C) and (D) contained anti rat a-LA serum drawn at three weeks and five weeks respectively in the center wells (Methods). 
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sites, presumably preserved through the different species• a-LA struc-
tures, eventually become expressed. This may account for the apparently 
conflicting claims for cross-reactivity of antihuman a-LA antibodies 
(65, 92). In double diffusion tests, both antisera had single precipi-
tin bands against their whey fraction, and no bands were seen against 
egg white lysozyme, rat serum alQumin, bovine serum albumin, bovine 
casein fraction, or against male rat or human sera. 
Immunoelectrophoresis of both rat and human a-LA was performed with 
their corresponding antisera and the results are shown in Figure 8. 
They indicate that there is a single precipitin arc against human a-LA, 
but two arcs for rat a-LA, which is a reflection of the different elec-
trophoretic mobilities of the charge isomers for rat a-LA (90). The 
same patterns were seen when reacted against their electrophoretically 
migrated whey fractions. 
Determination of the Optimal Conditions for the 
Radioimmunoassay for a-Lactalbumin 
Materials and Reagents 
GA-6 and GA-8 filters were purchased from Gelman. The filter mani-
fold unit Model P-10 was purchased from the Bradley Company. Poly-
ethylene glycol with average molecular weight 18,000 was obtained from 
Matheson. Carrier free 125I was purchased from New England Nuclear. 
Solutions of monoiodochloride, lactoperoxidase, and chloramine-T were 
supplied ~Y G. Polack and L. Walker respectively. Dowex-1-Cl, 50 to 100 
mesh, was purchased from Bio-Rad. Counting l25I was performed on 






Figure 8. Immunoelectrophoresis Against Anti-a-
Lactalbumin Sera 
Immunoelectrophoresis of samples containing a-LA 
was performed using antisera made in response 
to the purified human and rat a-LA. Panel (A) 
top well is purified human a-LA at 0.5 mg/ml, 
bottom well is the whey fraction of human milk, 
and the trough contains antihuman a-LA serum. 
Panel (B) top well is purified rat a-LA at 
0.5 mg/ml, bottom well is the whey fraction of 
rat milk, and the trough contains antirat a-LA 
serum. Electrophoresis was performed until the 
tracking dye was at the end of the trough. The 
troughs were then filled with their antiserum 




Iodination of a-LA was accomplished by three different techniques, 
i.e. monoiodochloride (93), chloramine-T (94), and lactoperoxidase (95). 
Separation of the free and covalently bound 1251 was accomplished by 
dialysis against 1% KI in H20 and binding of the free 1251 on Dowex-1-Cl. 
Purified 1251-a-LA was diluted with either 0.1 M KCl, 20 mM Tris, pH 7.4, 
or the same solution with 0.1% bovine serum albumin (w/v) added and 
stored at 4° C. 
Results 
Separating free 1251-a-LA from the antibody bound 1251-a-LA was 
achieved by precipitating the antibody 1251-a-LA complex with polyethy-
lene glycol. To demonstrate that the free 1251-a-LA molecules are not 
precipitated at 10% (w/v) polyethylene glycol while the antibody mole-, 
cules are precipitated, the following experiment was performed. One 
hundred ~1 of rat 1251-a-LA, containing 40,000 dpm with a specific 
activity of 80 ~Ci/~g, in 0.1 M KCl, 20 mM Tris, pH 7.4 with 0.1% bovine 
serum albumin, was made to various percentages of polyethylene glycol 
by the addition of 25% polyethylene glycol solution in water. The 
samples were thoroughly mixed and placed in an ice bath for 10 minutes, 
then filtered through GA-8 filters using the Bradley filter manifold. 
The filters were washed twice with 2 ml of polyethylene glycol of the 
same concentration used for that particular test point. The filters 
were placed in one inch aluminum foil squares and counted in the Packard 
gamma counter. Quench corrections were performed (96) and radioactivity 
measurements were based on disintegrations per minute. As shown in 





























































Figure 9. Effect of Polyethylene Glycol on the Precipi-
tation of Rat lz5r-a-Lactalbumin and Bovine 
y-Globulins 
One hundred ~1 samples of rat 125r-a-LA containing 40,000 
dpm were made to various percentages of polyethylene 
glycol, filtered through GA-8 filters, and the precipi-
tated radioactivity measured in a gamma counter. Sam-
ples of bovine y-globulins at 1 mg/ml were made to 
various percentages of polyethylene glycol and centri-
fuged at 30,000 x g for 20 minutes. The absorbance of 
the supernatant solutions was measured at 280 nm using 
the corresponding polyethylene glycol solution as the 
reference blank (Results). 
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glycol present. At 10% polyethylene glycol, only 1.5% of the total 
125r-a-LA molecules are retained on the filter above background trap-
ping. 
To determine the concentration of polyethylene glycol that would 
quantitatively precipitate the antibody molecules, the experiment shown 
in Figure 9 was performed. One ml samples of a 1 mg/ml bovine y-globulin 
solution in 0.1 M KCl, 20 mM Tris, pH 7.4 were made to various percent-
ages of polyethylene glycol by the addition of 25% polyethylene glycol 
in water. The samples were placed in an ice bath for 10 minutes then 
centrifuged at 30,000 x g for 20 minutes at 4° C. Absorbance at 280 nm 
of each supernatant solution was determined by referencing the solution 
against the appropriate percent polyethylene glycol solution. At 
10% polyethylene glycol concentration 99% of the antibody molecules are 
precipitated. These results indicate that at a 10% concentration of 
polyethylene glycol, the antibody molecules are quantitatively precipi-
tated while the 125r-a-LA molecules essentially remain in solution • 
. The principle of competitive binding assays, such as a RIA, requires 
that the antibody always be in a constant limiting amount. Therefore, 
the RIAs were performed using a serum dilution which could only bind 
50% of the available 125r-a-LA molecules. An antiserum dilution was 
sought which would bind 50% of the total 40,000 dpm of rat 125r-a-LA. 
Antirat a-LA serum was diluted with 0.1 M KCl, 20 mM Tris, pH 7.4 and 
100 p1 were added to 100 pl of rat 125r-a-LA (specific activity 80 pCi/ 
pg) containing 40,000 dpm in 0.1 M KCl, 20 mM Tris, pH 7 .4. The mix-
ture was incubated 24 hours at 4° C. Then 500 pl of 1 mg/ml bovine 
y-globulin in 0.1 M KCl, 20 mM Tris, pH 7.4 were added as carrier Y-
globulin, and 500 pl of 25% polyethylene glycol in water were added. 
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The solution was thoroughly mixed and placed in an ice bath for 10 
minutes, then filtered through GA-8 filters and washed twice with 2 ml 
of 8% polyethylene. glycol. Controls for each point were done by omit-
ting the antirat a-LA antibodies from the reaction mixtures. The 
filters were placed in one inch squares of aluminum foil and counted 
in a Packard gamma counter. The results shown in Figure 10 indicate 
that a serum dilution of 1 to 10,000 binds about 50% of the total rat 
125I-a-LA molecules added. 
The RIA is based upon the ability of the antibody molecules to 
recognize the a-LA molecules. It is important to determine what factors 
can influence this binding. The effect of pH was investigated by 
incubating antirat a-LA antibody and rat 125I-a-LA with different pH 
buffers. One hundred ~1 of antirat a-LA antibody solution diluted 
1:8000 with 0.1 M KCl, 5 mM Tris, pH 7.0 were incubated with 100 ~1 
of rat 125I-a-LA (specific activity 80 ~Ci/~g) containing 40,000 dpm 
in 0.1 M KCl, 5 mM Tris, pH 7.0. To this solution were added 100 ~1 
of the different pH buffers. The different buffers were all 0.1 M. 
Phosphate was used as the buffer at pH 2, pH 7, and pH 12. Citrate was 
the buffer at pH 4.5 and pH 5.8. Glycine was the buffer at pH 9.5. 
The samples were incubated for 24 hours at 4° C. Then 0.5 ml of 1 mg/ml 
bovine y-globulin in 0.1 M KCl, 5 mM Tris, pH 7.0 and 0.5 ml of 25% 
polyethylene glycol in water were added. The solution was vigorously 
mixed and placed in an ice bath for 10 minutes then filtered through 
GA-8 filters and washed twice with 2 ml of 8% polyethylene glycol. The 
filters were placed in aluminum foil squares and counted in a Packard 
garrma counter. Controls for each pH point were performed by omitting 
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Figure 10. Determination of Optimal Antiserum Dilution 
Rabbit antirat a-LA antiserum was diluted with the standard 
~~~ buffer and 100 ~1 were incubated with 100 ~1 of rat 
1-a-LA at 4° C for 24 hours. The polyethylene glycol 
precipitation techni~ue was used to separate free and . 
antibody bound rat 5I-~:,t-LA. One hundred percent repre-
sents 40,000 dpm of rat I25J-a-LA (Results). · 
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Figure 11, the optimal binding will occur between pH 7 and pH 9. Be-
cause the curve is slightly shifted towards basic conditions, 20 mM 
Tris, pH 7.4 was used as the buffering agent. 
The effect of ionic strength on antigen-antibody binding was 
investigated. As before, 100 ~1 of antirat a-LA serum diluted 1:8000 
with 5 mM Tris, pH 7.4 were added to 100 ~1 of rat 125r-a-LA {specific 
activity 80 ].lCi/~g) containing 40,000 dpm in 5 mM Tris, pH 7.4. To this 
solution were added TOO ~1 of solutions of KCl at different molar concen-
trations. Controls for each ionic strength point were done by omitting 
the antirat a-LA antibodies from the reaction mixtures. The samples 
were incubated, precipitated, washed, and counted as before. Figure 12 
shows that optimal binding occurs around 0.1 M KCl, and that binding 
is dramatically reduced in very low ionic strength solutions. Binding 
also drops to about 80% maximum and then levels off above 0.4 M KCl. 
Based on these results, the standard buffer for the RIAs contains 0.1 M 
KCl. 
Frequently, it is necessary to assay samples that have high 
protein concentrations. As pointed out by Viol et ~· (97), most RIAs 
can be inhibited nonspecifically by high protein levels resulting in 
false positive values. The effect of high protein levels on the a-LA 
RIAs was investigated by adding bovine serum albumin. Double diffusion 
tests indicated no cross-reactivity of either antiserum to bovine 
albumin. One hundred ~1 of antirat a-LA serum diluted 1:8000 in 
0.1 M KCl, 20 mM Tris, pH 7.4 were added to TOO ~1 of rat 125I-a-LA 
(specific activity 80 ~Ci/~g} containing 40,000 dpm in 0.1 M KCl, 20 mM 
Tris, pH 7.4. To this solution were added 100 ~1 of bovine albumin in 









































Figure 11. Effect of pH on the Rat a-Lactalbumin Radio-
immunoassay 
Rat 1251-a-LA and antiserum were incubated at 4° C for 
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24 hours in 0.1 M KCl buffered at the indicated pH values. 
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Figure 12. Effect of KCl on the Rat a-Lactalbumin 
Radioimmunoassay 
Rat 125I-a-LA and antiserum were incubated at 4° C 
for 24 hours in 5 mM Tris, pH 7.4 with the indi-
cated KCl concentrations. The polyethylene glycol 
preci pi tati on techni que1 ~gs used to separate free and antibody bound rat I-a-LA (Results). 
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for each protein level were done by omitting the antirat a-LA anti-
serum. The samples were incubated, precipitated, washed, and counted 
as before. As shown in Figure 13, nearly complete inhibition of anti-
gen-antibody binding can occur, if the protein concentration reaches 
high enough levels. A rather broad protein optimum occurs from about 
2 mg/ml to 10 mg/ml. Protein levels below 0.5 mg/ml can also produce 
low net dpm, possibly due to nonspecific binding of the antigen or 
antibody to the glass test tubes. Combining these data and the pre-
vious data, the standard buffer solution routinely used in the RIAs is 
0.1 M KCl, 20 mM Tris, pH 7.4 containing 1 mg/ml bovine serum albumin. 
It was necessary to determine whether the incubation temperature 
and the sequence of additio~ of the 1251-a-LA or unlabeled a-LA to the 
antibody would affect the level of sensitivity of the RIAs. Three 
sequences of addition were studied at two temperatures of 4° C and 
37° C. They were (1) preincubation of the antibody with unlabeled 
a-LA for 12 hours followed by addition of 1251-a-LA and 12 more hours 
of incubation, (2) preincubation of the antibody with 125I-a-LA for 
12 hours followed by addition of unlabeled a-LA and 12 more hours of 
incubation, and (3) simultaneous incubation of 1251-a-LA and unlabeled 
a-LA with antibody for 24 hours. One hundred ~1 of antirat a-LA serum 
diluted 1:8000 in the standard buffer were mixed with either 100 ~1 of 
rat 125I-a-LA containing 40~000 dpm in the standard buffer or 100 ~1 of 
standard buffer containing 0 to 40 ng of unlabeled rat a-LA. The 
200 ~1 mixtures were incubated for 12 hours at 4° C and 37° C. Then 
100 ~1 of rat 1251-a-LA were added to the tubes containing antirat a-LA 
antibody and unlabeled rat a-LA. Also, 100 ~1 of standard buffer con-
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Figure 13. Effect of Bovine Serum Albumin on the 
Rat a-Lactalbumin Radioimmunoassay 
Rat 125I-a-LA and antiserum were incubated at 
4° C for 24 hours in 0.1 M KCl, 20 mM Tris, 
pH 7.4 containing the indicated levels of 
bovine serum albumin. The polyethylene gly-
col precipitation technique was uizg to sepa-




antirat a-LA antibody and rat 1251-a-LA. The 300 ~l samples were then 
incubated for 12 hours more at the initial incubation temperature. 
Simultaneous incubation of 100 ~l of antirat a-LA antibody with 100 ~1 
of both rat 125r-a-LA and 100 ~1 of standard buffer containing unlabeled 
rat a-LA was performed at both temperatures for 24 hours. Controls for 
all points were performed by omitting the antirat a-LA antibody. The 
solutions were precipitated, washed, and counted as before. As shown 
in Figure 14, the incubation temperature had little effect on the sensi-
tivity of the assay. Incubation at 37° C caused only a slight drop in 
the net dpm. The significant observation is that preincubation of the 
antibody with the unlabeled a-LA produced the most sensitive assay. 
Simultaneous addition of 1251-a-LA and unlabeled a-LA with the antibody 
extended the usable range of the standard curve. Preincubation of the 
antibody and 125r-a-LA produced an unusable standard curve since essen-
tially all the antibody sites were occupied by the excess 1251-a-LA. 
Based on these experiments the standard conditions for both RIAs 
are as follows. The a-LA is iodinated by the iodochloride method to 
a specific activity of 80 ~Ci/~g. The standard buffer used to dilute 
the 1251-a-LA, the anti-a-LA serum, and the unlabeled a-LA for the 
standard curve is 0.1 M KCl, 20 mM Tris, pH 7.4 containing l mg/ml 
bovine serum albumin. The 125r-a-LA is diluted with the standard 
buffer to a level of 40,000 dpm/100 ~1. The anti-a-LA serum is diluted 
with the standard buffer to a level such that 100 ~1 will bind 50% of 
the added 125r-a-LA. This dilution is 1:8000 for the antirat a-LA 
serum currently used, and 1:6000 for the antihuman a-LA serum. The 
most sensitive assay utilizes sequenti'al addition of the antiserum 
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Figure 14. Effect of Temperature and Sequence of Addition of 
Reactants on Rat a-Lactalbumin Radioimmunoassay 
Antirat a-LA serum, rat 1251-a-LA, and unlabeled rat a-LA were 
incubated at 4° C (open symbols) and 37° C (closed symbols) 
using diffT~5nt sequences of addition. Free and antibody 
bound rat 1-a-LA were separated by the polyethylene glycol 
precipitation method (Results). 
At 4° C: 
c c (1) antibody+ 1251-a-LA for 12 hours, unlabel-
ed a-LA for 24 hours 
o--- o (2) antibody + unlabeled a-LA and 1251-a-LA for 
6--- --A 
At 37° C: ·------ __ .. 
•· ... ······• 






antib?~~ +unlabeled a-LA for 12 hours, 
1-a-LA to 24 hours 
antibody+ 1251-a-LA for 12 hours, unlabel-
ed a-LA to 24 hours 
antibody + unlabeled a-LA and 125I-a-LA for 
24 hours 
antibo~~ +unlabeled a-LA for 12 hours, 
I 0 1-a-LA to 24 hours 
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by addition of 125r-a-LA with incubation at 4° C for 12 to 24 additional 
hours. The antiserum and 125r-a-LA additions are each made in 100 11 1 
volumes, and the unlabeled a-LA addition can be made in 100 11 1 or 
400 11 1 volumes. Unknown samples must be within the limits of pH 
(pH 6.5 to pH 8.5), ionic strength (4 m mho to 22m mho}, and protein 
concentration (1 mg/ml to 10 mg/ml). 
Unbound 125r-a-LA is separated from antibody-bound 125r-a-LA by 
precipitation of the antibody-1251-a-LA complex with 10% polyethylene 
glycol. One-half ml of 0.5% bovine y-globulin in 0.1 M KCl, 20 mM Tris, 
pH 7.4 is added as carrier antibody. One-half ml of 25% polyethylene 
glycol in water is added to the 0.3 ml RIA, and one-half ml of 32% 
polyethylene glycol in water is added to the 0.6 ml RIA. After vigor-
ously mixing the sample which is then 10% in polyethylene glycol, it 
is placed in an ice bath for 10 minutes, then filtered through GA-8 
filters, and washed twice with 2 ml of 8% polyethylene glycol. The 
washed filter is placed in a one inch square of aluminum foil and 
counted in a Packard Model 5320 gamma counter. Quenching is corrected 
for by applying the appropriate formula and disintegrations per minute 
are determined. 
Controls for samples are done by omitting the antibody, and final 
net dpm is obtained by subtracting the ~ample's control dpm from the 
sample's experimental dpm. 
Using the standard method of the RIA, typical standard curves for 
human and rat a-LA, shown in Figures 15 and 16, respectively, are gen-
erated. 
The ability of a-LA from other species to cross-react with anti-







































Human a-Lactalbumin ng 
Figure 15. Standard Curve for the Human a-Lactalbumin Radio-immunoassay 
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Rat a-Lactalbumin ng 
Figure 16. Standard Curve for the Rat a-Lactalbumin Radioimmuno-
assay 
Antirat a-LA serum and unlabeled rat ~2~A were preincubated at 
4° C for 12 hours, followed by rat I-a-LA addition and 
incubation to 24 hours. Free and antibody bound rat a-LA 
were separated by the polyethylene glycol precipitation 
method (Results). 
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tive results from double diffusion studies described earlier were 
taken a step further by determining the quantity of a-LA from the 
various species which produces 50% inhibition of the maximum 1251-a-LA 
binding. Up to 100 pg of bovine, goat, guinea pig, and sheep showed 
no inhibition of rat 1251-a-LA binding to antirat a-LA antibodies. 
Human a-LA indicated a slight inhibition. However, as shown in Table I, 
the a-LAs from other species were able to cross-react with antibodies 
to human a-LA, although only when present at very high levels. 
TABLE I 
INHIBITION50 VALUES FOR a-LACTALBUMIN$ FROM 
DIFFERENT SPECIES DETERMINED BY THE HUMAN 
a-LACTALBUMIN RADIOIMMUNOASSAY 
a-LA I5o nanograms 
Human 0.7 
Rat 476 X 103 
Bovine 233 X 103 
Goat 25 X 103 
Guinea Pig 14 X 103 
Pig 28 X 103 
Sheep 116 X 103 
r50 - Level of a-LA which produces 50% 




a-LACTALBUMIN IN RAT MAMMARY TUMORS 
Materials and Reagents 
Rat mammary tumors were supplied by the Mason Tumor Bank as 
frozen whole homogenates. Trichloroacetic acid was purchased from 
Sigma. 
Methods 
The various rat mammary tumor samples which were received frozen 
from the Mason Tumor Bank were thawed and homogenized with a Polytron 
at setting six for two minutes at 25o· C in 20 mM Tris, 0.1 M KCl, 
pH 7.4, then centrifuged at 30,000 x g for 20 minutes at 4° C. Super-
natant solutions were assayed for a-LA by the standard RIA procedure. 
The R3230 AC tumor was maintained by subcutaneous trocar trans-
plantation into intact virgin female Fisher 344 rats (98). R3230 AC 
tumors grown for three weeks were removed and a cross-sectional segment 
through the center of the tumor approximately 5 mm thick was removed. 
Areas of the cross-sectional segment that were visually distinct were 
separated with scalpels in an attempt to select regions with different 
viability. The samples were placed in 0.1 M KCl, 20 mM Tris, pH 7.4 
and homogenized at room temperature with a Polytron at setting six for 
two minutes. The samples were centrifuged at 30,000 x g for 20 minutes 
at 4° C and the supernatant solutions were assayed for a-LA by the 
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standard RIA procedure. Protein values for samples were determined 
using the modified Lowry method of Hartree (99). 
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It was of interest to determine if a-LA would appear in the serum 
of rats bearing mammary tumors. A group of virgin female Fisher rats 
all weighing 100 grams were i.njected subcutaneously by trocar implanta-
tion with explants of the R3230 AC tumor weighing 4 mg. Another group 
of the rats were given an intraperitoneal injection of the 13762 MAT/A 
ascites fluid containing 107 cells. After an appropriate growth period, 
the rat was sacrificed by decapitation and the blood collected and im-
mediately centrifuged at 5000 x g for 20 minutes at 4° C to collect the 
serum. The serum was diluted four fold with 0.1 M KCl, 20 mM Tris, 
pH 7.4 and 400 ~1 of the diluted serum were assayed for a-LA by the 
standard RIA procedure •. 
To determine the half-life of a-LA in the blood, two methods were 
used. One hundred ~1 of radioactively labeled rat 125I-a-LA in balanced 
salt solution (0.14 M NaCl, 4 mM KCl, 0.5 mM Na2HP04, 0.17 mM NaH2P04 at 
pH 7.2) containing 30 ng a-LA with 250,000 dpm were injected by heart 
puncture into 150 gram virgin female rats anesthetized by intramuscular 
administration of pentabarbital (0.1 ml/150 g). Samples of blood were 
drawn by heart puncture at various times after 125I-a-LA injection, and 
200 ~1 were precipitated with 1 ml of 20% (w/v) trichloroacetic acid 
at 4° C. The samples were centrifuged at 30,000 x g for 15 minutes at 
4° C and the supernatant solution and pellet were separated and both· 
were counted in a Packard gaJTDTJa counter. Intact a.-LA molecules, both 
iodinated and non-iodinated are totally insoluble in 10% trichloroacetic 
acid at 4° C. The other method used 6 mg of unlabeled bovine a-LA dis-
solved in 200 ~1 of balanced salt solution which were injected by heart 
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puncture into 150 gram male rats anesthetized by intramuscular adminis-
tration of pentabarbital (0.1 ml/150 g). One ml samples of blood were 
drawn by heart puncture at various times after a-LA injection and 
immediately centrifuged at 5000 x g for 20 minutes at 4° C. Four hun-
dred J.ll of the serum were assayed for a.-LA using the spectrophotometric 
method. 
To determine the organs that are active in clearing a.-LA from the 
blood, labeled rat l25I-a.-LA was injected into male rats as before. At 
10 minutes, 3.5 hours, or 9 hours after injection of rat 125I-a.-LA, 
the rats were sacrificed by decapitation and drained of all possible 
blood. The entire organs of interest were removed, weighed, and counted 
in a Packard gamma counter. If it was impossible to remove the entire 
organ, representative areas were selected, weighed, and counted. 
Results 
a.-Lactalbumin Levels in Rat Tumors 
The Mason Tumor Bank has characterized its stock of mammary carci-
nomas by histological evaluation of thin sections into the broad classes 
indicated in Table II. Unfortunately these designations do not relate 
quantitatively to the biochemical status of the tumors. Utilizing 
the levels of the marker protein a.-LA, one can evaluate whether a range 
of differentiation exists within the group of tumors designated adeno-
carcinomas. 
It is interesting to note that the three tumor lines induced by 
DMBA showed a 56 fold dtfference in a.-LA levels as determined by RIA. 
The tumor designated DMBA #14 was classified as an adenocarcinoma but 


























Squamous Cell Carcinoma 














logically designated as a squamous cell, carcinoma. Another interesting 
result is seen by comparing the parent 13762 tumor, which was induced by 
DMBA, with its three derived ascites lines. The solid parent tumor 
synthesizes a rather low level of a-LA and readily metastasizes. The 
three ascitic lines all produce significantly lower levels of a-LA. 
Microscopically, the B line is characterized by a suspension of small 
clumps of five to ten cells. The C line, on the other hand, is a single 
cell suspension characterized by the lack of small clumps of cells. The 
C line cells are almost twice as large as the A line, vacuolated cells 
appear more common, and intracytoplasmic fat droplets appear to be more 
numerous in the C line. The A line is a mixture of the 8 and C line 
cell populations (100). The values for a-LA in the three cell line 
agree with their histological description. 
The R3230 AC tumor has the highest a-LA level, being 1.5 times 
as high as the next tumor, DMBA #la. This level of a-LA corresponds 
to an early lactational or late regressional normal rat mammary gland, 
and therefore probably represents a suitable rat model for a minimally 
deviated mammary adenocarcinoma. 
Cross-sectional Analysis of R3230 AC Tumors 
One aspect of most tumor growth is that, due to their rapid growth 
rate, central areas of necrosis usually develop. By selecting areas of 
tumors that were visually distinct, analysis of a-LA levels by RIA were 
made in central necrotic regions and the more viable peripheral regions. 
The data shown in Table III i.ndicate that the periphery contains the 
highest level of a-LA and that, as one nears the focus of tumor growth, 
a-LA levels steadily drop. The areas of necrosis are characterized 
TABLE III 











The sections are from the periphery to the center. The 
periphery was about 10%, second layer 35%, third layer 
35%, and center 20% of the cross section. 
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microscopically by local invasion of polymorphonuclear granular leuko-
cytes, which digest the tumor cells leaving a semi-liquified debris. 
Realizing a-LA•s resistance to proteolytic digestion, it is not unrea-
sonable to expect some a-LA to survive the necronizing systems. Further, 
microscopic examination of the visually selected areas reveals an ex-
tremely sharp border between necrotic and non-necrotic areas which are 
impossible to cleanly separate by visual methods. This results in some 
overlap of tissue types between selected tissue regions. 
Correlation of Serum a-Lactalbumin Levels with 
Tumor Growth 
In 1972 Ebner and McKenzie (101) used the incorporation assay to 
analyze sera from male, female, and lactating rats for a-LA. They re-
ported significant levels of a-LA in all lactating rats, with undetecta-
ble levels in male or female rats. This observation indicated that an 
elevated level of a~LA in the serum of a non-lactating person might be 
an indication of a breast lesion. To determine whether serum from tumor 
bearing rats would contain significantly elevated a-LA levels, sera 
samples from rats bearing the R3230 AC and 13762 ascites A line were 
collected at various stages of tumor growth. Analysis for a-LA by RIA 
indicated that significant serum levels of a-LA were attained as shown 
in Figure 17. The 13762 A line produced measurable levels of a-LA in 
its serum within two days after intraperitoneal injection of approxi-
mately 107 cells. Death for these rats occurred on days 11 and 12, 
but distention of the abdomen was not observable until day 4. The 
R3230 AC tumor took longer to produce detectable serum a-LA levels, but 




























Figure 17. Levels of a-Lactalbumin in Sera 
of Tumor Bearing Rats 
Rats were transplanted with the R3230 AC rat 
mammary adenocarcinoma (•____.) and the 
13762 MAT/A ascities line (•----•). Serum 
samples were collected on the indicated days 
after injection, diluted, and assayed for 
a-LA by the standard RIA procedure (Methods). 
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following tumor transplantation of 30 days, but one survived 56 days 
and developed bilateral tumors which weighed a total of approximately 
20 grams. Serum from a 12 day lactating rat was also assayed and the 
level determined was 350 ng a-LA/ml. 
Clearance of a-Lactalbumin from Blood 
Since a-LA was detectable in sera from tumor bearing rats, it was 
of interest to determine its rate of clearance from blood. The most 
straight-forward method was to inject rats with radioactively labeled 
rat a~LA and measure the decline in radioactivity in blood with time. 
As shown in Figure 18, the radioactivity precipitated by trichloroacetic 
acid, which represent intact a-LA molecules, declined in an apparent 
first order process with a 3.5 hour half-life. The initial trichloro-
acetic acid soluble radioactivity, which probably represent oxidation 
fragments of a-LA produced by the iodination reaction or by radiation 
damage, also drop at approximately the same rate. If proteolysis of 
a-LA were occurring in the blood, or if the organs which remove a-LA 
from blood were metabolizing it and secreting small fragments back into 
the blood, one would expect to see an increase in trichloroacetic acid 
soluble radioactivity. Iodinated a-LA is readily recognized by anti-
bodies to unlabeled a-LA, indicating that the conformation of the de-
terminants is preserved after iodination. However, to be certain that 
the iodination had not introduced a molecular alteration which would 
change the clearance rates, normal a-LA was also tested. Bovine a-LA 
was injected by heart puncture into a rat and sera samples drawn at 
various times after injection were assayed for a-LA specrophotometri-































Hours After Injection 
Figure 18. Clearance Rate of a-Lactalbumin from Blood 
One hundred ~l of rat 1251-a-LA in balanced salt solu-tion containing 240,000 dpm of trichloroacetic acid insoluble a-LA molecules and 10,000 dpm of trichloro-acetic acid soluble material were injected by heart puncture into norma·l virgin female rats. Blood sam-
ples were drawn at the indicated times after injec-tion. The samples were precipitated by 20% trichloro-acetic acid at 4° C, centrifuged at 30,000 x g for 20 minutes and the supernatent solution (o----o) and the pellet (c----o) analyzed in a gamma counter. Six mg of bovine a-LA in 200 ~l of balanced salt solution were also injected by heart puncture into male rats. Blood samples were drawn by heart puncture and immedi-ately centrifuged at 5,000 x g for 20 minutes. The sera were assayed for a-LA by the spectrophotometric method at 340 nm ( .....__ - ----.) (Methods). 
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identical to the half-life determined for the iodinated a-LA, and the 
clearance seemed to be first order. The amount of radioactively labeled 
a-LA injected was approximately 30 ng, whereas 6 mg of nonlabeled a-LA 
were used for the latter experiment. Since both levels had half-lives 
of 3.5 hours, this is supportive evidence that the clearance is a first 
order process which is independent of the level of a-LA. 
The organs that are responsible for the clearance of a-LA from the 
blood are shown in Table IV. Due to instrument failure caiculation of 
disintegrations per minute were not possible, but based on previous 
experiments, a low consistent level of quench is observed in tissues~ 
The liver has the highest total cpm followed closely by the kidneys and 
the lungs. Then there is a sharp drop in cpm to organs such as muscle 
and spleen which contain extensive capillary beds. Feces count rates 
were also low but positive. Collection of the urine revealed a deceiving 
count rate for valid a-LA. Greater than 96% of the counts in urine 
are not trichloroacetic acid precipitable, indicating that the trace's 
endogenous trichloroacetic acid soluble material, which represented 
about 4% of the total cpm injected, is probably filtered by the kidneyo 
Total calculated recovery of the injected 125I-a-LA from the organs 
surveyed was about 92%, and in no experiment did the trichloroacetic 
acid soluble counts appearing in the urine exceed the tota1 trichloro-
acetic acid soluble counts injected. This result is congruent with 
the inability to detect a-LA by RIA in the urine of normal lactating 
rats. Sacrificing the rats at various times after injection of the 
labeled a-LA did not alter the relative levels of radioactivity seen 
in the different organs. 
These data suggest that a great range of differentiation, as evalu-
TABLE IV 
CLEARANCE OF SERUM a-LACTALBUMIN BY VARIOUS ORGANS 
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*Representative portion of organ. 






































ated by a-LA levels, exists in rat mammary carcinomas used as models 
for human breast cancer. In addition, since a-LA is found normally 
only in the sera of lactating rats, abnormally high serum a-LA levels, 
such as those found in tumor bearing animals, might be diagnostic 
for a breast lesiono However, the ability of many organs to clear 
large amounts of a-LA from the blood in a short time keeps the serum 
a-LA levels low, except in highly secretatory periods. Unfortunately 
the kidneys do not appear to clear valid a-LA to the urine. 
CHAPTER V 
a-LACTALBUMIN AND HUMAN BREAST DISEASES 
Materials and Reagents 
Fresh human tissues were obtained from the departments of Surgery 
and Surgical Pathology at Kansas University Medical Center. Pre-
surgery sera from breast cancer patients were obtained from the files 
of the Detection Center for Breast Disease at Kansas University Medical 
Center and control sera were collected from normal male and female 
volunteers. Sera were also collected from women at various periods of 
the lactational cycle. The cultured human cell lines were supplied by 
the Mason Tumor Bank and were grown under recommended conditions. Cells 
harvested from logarithmic growth phase were termed normal growth condi-
tions. To examine the effect of cell density on a-LA levels, cells 
were grown at high density (loB cells/cm2) and low density (lo6 cells/ 
cm2) with insulin, hydrocortisone, and prolactin all present at a 
5 vg/ml concentration. The solid tumors, produced by injection of human 
cell culture lines into the nude mouse, were supplied by Dr. B. Giova-
nella, the Stehlin Foundation for Cancer Research, Houston, Texas. 
The P-50 ultra-filtration centrifuge cones with an approximate 
molecular weight exclusion limit of 50,000 were purchased from Amicon. 
Pepsin was purchased from Curtis-Matheson Chemical Corporation as a 




The cultured human cell lines were received as a centrifuged 
pellet of cells which had been quickly frozen and shipped in dry-ice. 
The cells were thawed and resuspended in a small volume of 20 mM Tris, 
0.1 M KCl, pH 7.4, then homogenized with a Polytron at setting five 
for two minutes at room temperature, and centrifuged at 30,000 x g 
for ten minuteso The supernatant solution was assayed for a-LA by the 
standard RIA procedure. The solid tumors produced in the nude mice 
by subcutaneous injection of cultured cells from human lines, as well 
as fresh tumors removed by surgery, were received frozen and intact. 
This allowed for selection of non-necrotic areas of tissue. They were 
also homogenized and centrifuged by the procedure described above. 
Sera from patients with breast carcinomas and control sera were 
centrifuged in the Amicon P-50 ultra-filtration centrifuge cones at 
950 x g for 60 minutes in a swinging bucket rotor number 849 with the 
International centrifuge, model number PR-2. These cones effectively 
removed all the serum proteins with molecular weights greater than 
50,000, while allowing the smaller a-LA molecules to be filtered through 
and collected with the serum•s liquid fraction. The cones were pre-
treated by washing with deionized H20, and were reconditioned by over-
night incubation in Dol% pepsin solution followed by an extended soaking 
in a 1 M NaCl, 10% ethanol solution. 
Urine from lactating women 1 to 3 days postpartum and urine from 
normal control subjects were cooled to 4° C and centrifuged at 30,000 x 
g for 20 minutes to remove any precipitate. The supernatant solution 
was assayed directly for a-LA by the standard radioimmunoassay method. 
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Results 
Analysis of Primary Human T~mors 
Although knowledge of the biochemical degree of differentiation of 
human mammary carcinomas would obviously be very important, no one to 
date has measured primary mammary tumors for a-LA or casein. Based on 
the data from the rat model systems, one might expect a wide range of 
differentiation among breast carcinomaso Frozen tissue from primary 
mammary carcinomas is difficult to obtain, but a reasonable number were 
assayed for a-LA by RIA. As shown in Table V, a rather high percentage 
of the breast carcinomas had detectable levels of a-LA, but these 
levels were low when compared to the highly secretatory R3230 AC or 
DMBA tumors. Histological examination of the tissues designated as 
breast carcinomas by pathologists revealed a wide range of cellular 
structures which ranged from adenoid to fatty, and gave correspond-
ingly wide ranges of a-LA. Normal non-lactating breast tissue, which 
contains few epithelial cells surrounded by many fat cells, was negative 
for a.-LA. The two cases of lymph node metastases from a-LA positive 
primary tumors were also positive. In addition, the metastases closely 
resembled the parent tumors in cellular architecture, as evaluated by 
hematoxylin and eosin staining. Of considerable significance was that 
all the benign fibrocystic, fibroadenoma, or adenoma tumors produced 
a.-LA. The mucinous ovarian carcinoma was a-LA positive and may repre-
sent an ectopic production of a-LA, but the pancreatic tumor, lung 
carcinoma, and spleen myelofibrosis were negativeo The case of male 
gynecomastia was negative. This benign disease occurs in response to 




























a-LACTALBUMIN LEVELS IN HUMAN TUMORS 























































Correlation of a-LA levels to classic examples of breast diseases 
would be an obvious aid in clinical differential diagnosis of breast 
masses which determines the correct operative treatment. 
Analysis of Human Cell Culture Lines 
In addition to maintaining a depository of rat model tumors, Mason 
Tumor Bank has attempted to place purported human mammary cells from 
several sources into stable cultured lineso The general procedure is 
to obtain cells by pleural effusion from patients with different types 
of breast carcinomas, based on a theory that the cells comprising the 
pleural fluid will be derived from the primary tumor. This technique 
offers the advantage of providing cells that are already dispersed 
into single cells, rather than having to mechanically or enzymatically 
disperse a solid tumor into isolated cells, which one could then attempt 
to place into cell culture. Some objections to the pleural effusion 
technique have been raised. One point in question is, can one be 
reasonably sure that the majority of cells comprising a pleural effusion 
are valid mammary carcinoma cells. Further, even if the cells are 
spawned by the primary tumor, do they still retain any biochemical 
similarity to the original tumor, or have they undergone significant 
alt~rations of gene expression which are inherent prerequisites demand-
ed by the metastasizing process. These pertinent questions have not 
been answered. The presence of a-LA in the cells could help to estab-
lish their parentage and their level of differentiation. Indeed, there 
have been some indications that human lines in culture which were 
thought to be mammary cells are actually Hela cells (4)o 
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In an attempt to establish the cell parentage and degree of differ-
entiation of the cell lines carried by the Mason Tumor Bank, samples 
were analyzed for a-LA by the RIA. As shown in Tab1e VI, three lines 
were obtained by pleural effusions of different types of mammary carci-
nomas, -the HBL-100 line was obtained from tells present in breast milk, 
and a line was obtained from normal amnion fluid. None of the lines 
contained levels of a-LA significantly above the limit of det~ction, 
i.e. above 0.3 pg a-LA/~g protein, when harvested in logarithmic growth 
phase without hormones. Since normal breast tissue is not actively 
dividing while synthesizing milk proteins, it was of interest to deter-. 
mine whether slower growth rates and hormones could stimulate the cells 
to form a-LA. Cells were grown in high and low density in the presence 
of hormones insulin, hydrocortisone, and prolactin, and then assayed 
for a-LA by RIA. These modifications of growth conditions were not 
successful in raising a-LA levels above background. Sinte neither 
the original parent tumors nor the original pleural effusions were 
analyzed for a-LA, one ~annat be sure whether the cells were ever suf-
ficiently differentiated to synthesize a-LA, or whether the cells lost 
the ability due to the non-physiological conditions inherent with in 
vitro culturing. 
Another ingenious method for slowing the rate of cell replication, 
for replacing cell-cell contact, and for providing nutrients found in 
blood to human tumor cells, is to employ the nude, or athymic, mouse 
as a growth vehicle. Since this mouse strain has. essentially no cell 
mediated immunological response, foreign tissues fromantigenically 
different species are not usually rejected. This.allows one to place 
human cells back into an in vivo system with very nearly normal physio-
Cell Line 
HBL-100 





a-LACTALBUMIN LEVELS OF HUMAN CELL CULTURE LINES 
pg a-LA/~g Protein 
Cell Origin Log Growth High Density Low Density 
Normal Breast Milk <0.3 <0.3 <0.3 
Pleural Effusion of Infiltrating 
Ductal Carcinoma <0.3 <0.3 <0.3 
Pleural Effusion of Metastasizing 
Medullary Carcinoma 0.6 <0.3 <0.3 
Pleural Effusion of Poorly Differ-
entiated Papillary Carcinoma 0.3 0.3 <0.3 
Norma 1 Epithelia 1 Cells from 




logical conditions which are unattainable in cell culture. Following 
subcutaneous injection of the tumor cells, solid tumors were produced 
which were analyzed for a-LA by RIA. Comparison of a-LA levels from 
the cells grown in culture conditions with the a-LA levels in solid 
tumors would indicate whether factors critical for expression of dif-
ferentiated functions are missing under in vitro conditions of cell 
culture. Table VII indicates that the BT-20 cell line does not have 
measurable a-LA levels in cell culture, nor do the solid tumors pro-
duced by the cell lines designated CO-l, CL-1, and ST-1. Analysis of 
the solid tumors produced by the BT-20, KE-1, and GI-l cell lines have 
given variable resultso One set of tumors produced significant levels 
of a-LA, but the second set of tumors produced undetectable levels. 
Histological techniques to be discussed later supported the negative 
RIA results. 
Analysis of Sera from Breast Cancer Patients 
Analysis of the primary tumors and their metastases indicated a 
significant percentage synthesize detectable levels of a-LA. Analysis 
of presurgical sera could indicate what proportion of breast carcinomas 
synthesize a-LA at a level that is sufficient to produce a significant 
increase in serum a-LA concentrationo As pointed out previously, RIAs 
can give false positive values if non-specific protein levels reach 
high enough levels, such as found in non-diluted serum. To avoid this 
problem, sera were filtered through Amicon ultra-filtration centrifuge 
cones which allowed small molecular weight components such as a-LA to 
pass through while retaining compounds with molecular weights greater 









, TABLE VII 
a-LACTALBUMIN LEVELS OF HUMAN CELL LINES GROWN IN NUDE MICE 
pg a-LA/~g Protein 
Cell Origin Sample 1 Sample 2 
Primary Culture of Carcinoma 
Eighth Passage of Primary Culture 
Pleural Effusion of Breast Carcinoma 
Fifteenth Year of Culturing 
Fifteenth Year of Culturing 
Pleural Effusion of Breast Carcinoma 















tion is consisteritly within a range of 1 mg/ml, which is ideal for the 
RIA. Recovery of a-LA was rigorously checked by adding known amounts 
of bovine a-LA to serum and then monitoring its recovery in the filtrateo 
The cones exhibited a consistent recovery of 83 ± 5%, and were periodi-
cally rechecked for recovery level and cleaned after each usage by a 
pepsin digest with an alcohol and salt washo Analysis of 38 presurgical 
breast carc.inoma sera indicated that ten had a-LA levels significantly 
elevated above the control sera as shown in Table VIII. Male control 
sera were all negative. By examining sera taken from normal women at 
different points during the menstrual cycle who were or were not using 
birth control .pills, it was determined that there is no normal rise 
and fall of a-LA in their serum which can be attributed to normal 
physiological processeso Analysis of postsurgical sera from the patients 
who had elevated presurgical serum a-LA levels indicated no detectable 
level of a-LA, indicating removal of the tumor removed the source of 
a-LA production. The level of detection of a-LA in serum is D.l5 ng 
a-LA/ml and values below this level are reported as DoDo 
Analysis of Urine from Lactating Women 
The kidneys effectively filter small molecules across the glomeru-
lar basement membrane. Myosin, which has a molecular weight of 17,5DD, 
has a glomerular filtration ratio of Do97 indicating it is readily 
filtered into the glomerulus (1D3)o Since a-LA has a smaller molecular 
weight, one would suspect it would also be filtered from the blood. 
Normal urine has approximately 2D ~g protein/ml and a conductivity of 
12 m mho, b~th of which are within the optimum ranges for the RIA. If 
a-LA is filtered by the kidneys, it probably would be in higher concen-
TABLE VI II 




M-1 t W-lt W-3, W-4, W-5t 
W-7t W-8, W-9, W-iO, w~11 
W-12, W-13, W-14, W-15, 
U-1. U-2, V-1, V-2, LO, 












1-M, 2-M, 1-F, 2-F 
1-M, 2-M - normal male sera 




























tration in the urine than it is in serum, and urine samples would not 
have to be deproteinized before they could be analyzed by RIA. Samples 
from six lactating women who were one to three days postpartum were 
analyzed by RIA along with urine from four normal males and three normal 
females. As shown in Table IX, no a-LA was detectable in the controls 
or lactating urineso To ensure that some compound present in urine 
was not prohibiting detection of a-LA, a known amount of a-LA was added 
to a lactating urine, and no inhibition of its detection was noted. 
These data strongly indicate that, although a-LA is theoretically small 
enough to be filtered by the glomerulus, a-LA is not collected in urine. 
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TABLE IX 
a-LACTALBUMIN LEVELS OF URINE FROM LACTATING WOMEN 
Subject Condition ng a-LA/ml 
RO Lactating 0.0 
MU Lactating 0.0 
KE Lactating 0.0 
CL Lactating 0.0 
BI Lactating 0.0 
HA Lactating 0.0 
LB Male Control 0.0 
GS Male Control 0.0 
CG Male Control 0.0 
IN Male Control 0.0 
ss Female Control 0.0 
cc Female Control 0.0 
RS Female Control 0.0 
HA Lactating + a-LA (4 ng) 4.0 
HA Lactating + a-LA ( 8 ng) 8.0 
CHAPTER VI 
ANALYSIS OF RAT AND Hm1AN TUMORS FOR a.-LACT-
ALBUMIN BY HISTOCHEMICAL METHODS 
Immunofluorescence System 
Materials and Reagents 
Fluorescein labeled goat antirabbit y-globulin was purchased from 
Pentex. Rat serum albumin was purchased from Sigma. Slides were viewed 
on a Zeiss fluorescent microscope Model RA equipped With FL barrier 
filter inserts, Neofluor objectives, and HB0-200 illuminator. Photo-
graphs were taken with a PM-10 Olympus 35 mm camera using Kodak EHB-135 
film. A Cryo-Cut cyrostat manufactured by American Optical Company was 
used to cut frozen sections. Balanced salt solution was 0.14 M NaCl, 
4 mM KCl, 0.5 mM Na2HP04, 0.17 mM NaH2P04 at pH 7.2. 
Methods 
Detection of antigens by the indirect or Coons (76) method has been 
exploited for numerous systems. In general terms the basic procedure is 
to apply a solution which contains antibodies directed against the 
desired antigen on a thin section of the tissue to be tested. After an 
appropriate incubation period, the tissue section is washed until the 
unbound antibodies are removed, and a second fluorescein labeled anti-
body solution which is directed against the first antibody molecules is 
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applied. After further incubation and washing, the sections are mount-
ed in glycerol and viewed with an ultraviolet fluorescent microscope. 
Intensity of fluorescence is judged to 0.5 units on a unitless scale of 
increasing fluorescence from 0 to 8 by double blind evaluation of two 
investigators. Values were reported as the average of the two investi-
gator's values. 
The procedure used for the immunofluorescence system was as follows. 
Specimens of frozen tumor tissue were cut on a cryostat at -20° C pro-
ducing 4 to 6 micron thick sections. Due to its fatty nature, it was 
necessary to cut lactating mammary gland tissue sections at 10 to 14 
micron thickness. The sections were placed on glass slides and air-
dried for 30 minutes at room temperature. The slides were placed in 
10% neutral buffered formalin (10% formaldehyde (v/v) in 50 mM phosphate, 
pH 7.0) for either 5 minutes or 18 hours. After fixation, they were 
washed at room temperature in balanced salt solution for 1 hour. The 
anti-a-LA serum and the normal rabbit serum were diluted 10 fold with 
balanced salt solution, male rat serum or male human serum. The 
fluorescein-labeled goat antirabbit y-globulin was diluted 50 fold with 
balanced salt solution. 
Four slides were necessary for each experimental condition and were 
designated immune serum, normal rabbit serum, goat antirabbit y-globulin, 
and autofluorescence. The immune serum slide and normal rabbit serum 
slide, which serves as a control, received their respective serum fol-
lowed by the fluorescein-labeled goat antirabbit y-globulin serum. The 
control slide designated goat antirabbit y-globulin received no rabbit 
serum treatment but received only the goat antirabbit y-globulin serum. 
The autofluorescence control slide had no serum treatment. 
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Performing all incubations and washings at room temperature, the 
immune serum, containing anti-a-LA antibodies, an~ normal rabbit serum 
were applied to their slides for 30 minutes, and then washed for 30 
minutes in balanced salt solution. The fluorescein labeled goat anti-
rabbit y-globulin serum was applied to the immune serum slide, to the 
normal rabbit serum control slide, and to the goat antirabbit y-globulin 
control slide. The three slides were incubated for 30 minutes and 
washed for 30 minutes in balanced salt solution. All four slides were 
then mounted in glycerin and evaluated by the double blind procedure. 
During the development of this final optimized procedure for 
demonstration of a-LA by immunofluorescence, several important observa-
tions were made. Treatment of mammary tissue by the different fixing 
reagents acetone, ether/alcohol, acetic acid, and formalin indicated 
that 10% neutral buffered formalin produced the best tissue preserva-
tion with the least introduction of autofluorescence. Because frozen 
mammary tissue is extremely difficult to section thinly, attempts were 
made to use the paraffin embedding process. Sections 5 microns thick 
can easily be cut from paraffin blocks, and tissue preservation is 
excellent. However, mammary tissue develops severe autofluorescence 
during the dehydration process, and thereby renders paraffin sections· 
totally unusable for fluorescence studies. It was necessary, therefore, 
to utilize only frozen tissue samples. 
Because both the antirat a•LA and the antihuman a-LA sera have 
hig~ titers, a 10 fold dilution of the antisera produced fluorescence 
as intense as nondiluted serum, but a 20 fold dilution was less intense. 
Similarly, a 50 fold dilution of the fluorescein labeled goat anti-
rabbit y-globulin was determined to be the optimal concentration. 
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Incubation of the sera with tissue sections at 37° C or 4° C produced 
less net fluorescence than at 25° C. Incubation of the test sera with 
the tissues produced no additional net fluorescence after 30 minutes. 
Similarly, 30 minute washes of the tissues were sufficient to remove 
nonspecifically bound y-globulin. 
As will be discussed later, it has been theorized that mammary 
secretory epithelial cells possess specific y-globulin receptors on 
their plasma membranes. Since the vehicle used to recognize the desired 
antigen is a y-globulin molecule, this adds another dimension to immuno-
fluorescence on frozen sections of mammary gland. If they-globulin 
receptors of the test tissue recognize they-globulins from the species 
used to generate either the first or second antibody, then binding and 
finally fluorescence will occur whether or not the particular antigen 
is present. This problem can be resolved in two ways. One can q.ttempt 
to block they-globulin receptors with a y-globulin to which the second 
fluorescein labeled antibody does not cross-reacto Alternatively, one 
can try to inactivate the y-globulin receptor with denaturents which 
do not destroy the determinants of the antigen in question. Both methods 
were successfully employed. 
For the following experiments, two objectives were in mind: first, 
to detect a-LA in tissues, and second, to demonstrate the ability to 
block they-globulin receptors or destroy their activity. Four rat 
tissues were investigated; normal mammary gland from a 12 day lactating 
Fisher rat, R3230 AC tumor, solid 13762 tumor produced by subcutaneous 
injection of 13762 ascites cells of the MAT/A line, and 13762 ascites 
cells of the MAT/A line. Two human mammary tissues were investigated; 
a fibrocystic disease and an adenomao All were sectioned and fixed as 
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described before • 
. Results 
To determine the spectrum of cross-reactivity of the fluorescein 
labeled goat ahtirabbit y-globulin, double diffusion tests were carried 
out at 25° C in 1% agar in 0.1 M KCl, 20 mM Tris, pH 7.4. The antigens 
tested were undiluted male rabbit serum, male rat serum, male human 
serum, and bovine y-globulins at 10 mg/ml, bovine serum albumin at 
30 mg/ml, and rat serum albumin at 30 mg/ml, all in balanced salt solu-
tion. Only male rabbit serum produced any precipitate band, indicating 
that the fluorescein labeled goat antirabbit y-globulin antibodies would 
recognize only rabbit y-globulins. This would allow an attempt to block 
they-globulin receptors on rat and human mammary tissues with several 
y-globulins. 
By performing simultaneous experiments on tissue sections which had 
been fixed in formalin for 5 minutes or 18 hours and by using antibody 
solutions which did or did not contain blocking y-globulins, it was 
possible to demonstrate (1) the presence of a-LA; (2) the susceptibility 
of they-globulin receptors to chemical modification; and (3) the ability 
to block they-globulin receptors withy-globulins to which the fluores-
cein labeled goat antirabbit y-globulin antibodies did not cross-react. 
As shown in Table X, the sections of lactating rat mammary gland that 
were fixed for 5 minutes had a net difference in fluorescence of 0.7 
for sections treated with immune serum and normal rabbit serum when rat 
serum was not present to block they-globulin receptors with rat y•globu-
lins. By incubating the sections fixed for 5 minutes in formalin with 
the test sera that contained male rat serum, the net fluorescence was 
TABLE X 
EVALUATION OF a-LACTALBUMIN IN NORMAL AND RAT t~MMARY CANCERS BY IMMUNOFLUORESCENCE 
5 min NBF 
Anti serum 
Test Diluted in 
Tissue Serum Balanced Salt 
IS 4.2 
Lactating Rat NRS 3.5 
Mammary Gland GARyg 0.0 
Net 0.7 
IS 2.5 




13762 MAT/A NRS 2.5 
Solid GARyg 1.0 
Net 0.7 
IS 4.0 
13762 MAT/A NRS 2.0 
Asci ties GARYg 0.0 
Net 2.0 
NBF - neutral buffered formalin 
GARyg - goat antirabbit y-globulin 
5 min NBF 18 h NBF 18 h NBF 
Antiserum Anti serum Antiserum 
Diluted in Diluted in Di 1 uted in 
Male Rat Serum Balanced Salt Male Rat Serum 
4.5 5.0 4.5 
1.2 2.2 1.2 
0.0 0.0 0.0 
3.3 2.7 3.3 
2.5 3.5 2.5 
0.2 1.5 0.0 
0.0 0.0 0.0 
2.3 2.0 2.5 
1. 5 3.0 2.5 
0.0 1.0 0.2 
0.0 0.5 0.0 
1.5 2.0 2.3 
3.0 3.0 2.0 
0.0 1.0 0.0 
0.0 0.0 0.0 
3.0 2.0 2.0 
IS - Immune Serum 




increased to 3.5. The net increase was caused by the dramatic drop in 
fluorescence of the normal rabbit serum control slide. This indicated 
indirectly that the excess rat y-globuJins were effectively occupying 
the majority of the tissue's specific y-globulin receptors. Since the 
goat antirabbit y-globulin antibodies do not cross-r~act with rat 
y-globulins, the nonspecific background fluorescence represented by 
the normal rabbit serum slide was drastically reduced. The goat anti-
rabbit y-globulin slides were all 0.0, indicating that they-globulin 
receptors on rat mammary tissue do not recognize goat y-globulins. 
Further experiments with other blocking molecules indicated that bovine 
y-globulins, bovine serum albumin, human y-globulins, and rat serum 
albumin could not decrease the fluorescence of the normal rabbit serum 
control slide. This indirect evidence is complementary to the direct 
evidence data presented in Chapter VII which indicates that the y-globu-
lin receptors of rat mammary epithelial cells are specific and do not 
recognize human or bovine y-globulins. 
The sections incubated 18 hours in formalin showed much less evi-
dence of active y-globulin receptors. The section treated with normal 
rabbit serum which did not contain blocking rat serum had a fluorescence 
value of 2.2, and when excess rat serum was present, the value moder-
ately dropped to lo2o 
The net fluorescence value indicates the level of a-LA, and identi-
cal values are obtained for both the 5 minute and 18 hour formalin 
treated sections if blocking rat serum is used. Omitting the rat 
y-globulins produced a net increase from 0.7 to 2.7 caused by the 
extended formalin fixation. 
As shown in the photographs in Figure 19, the immune serum produced 
Figure 19. Photomicrographs of Lactating Rat Mammary Gland Using the 
Immunofluorescence Method for Detection of Rat a-Lact-
albumin 
Sections of lactating rat mammary gland were fixed in neutral buffer-
ed formalin for 18 hours. The top panel is tissue treated with 
rabbit antirat a-LA serum diluted with male rat serum followed by 
fluorescein labeled goat antirabbit y-globulins. The bottom panel 
is tissue treated with normal rabbit serum diluted with male rat 




fluorescence that was located entirely in the cytoplasm. The nuclei of 
the epithelial cells forming the ascini appeared as black holes. The 
supporting stromal elements were also negative. Secretory products 
present in some lumen which were not washed out also fluoresced intense-
ly. Control tissues such as rat muscle gave zero fluorescence for all 
three test sera. 
Similar results were obtained for the other three rat tissueso All 
had demonstrable levels of a-LA which were in qualitative agreement with 
the levels determined by RIA. 
Two additional experiments were performed to conclusively demon-
. strate the specificity of the immunofluorescence/horseradish peroxidase 
systemso Pure rat a-LA was added to 10 fold diluted rabbit antirat a-LA 
serum (4 mg pure rat a-LA/ml diluted antirat a-LA serum), then this serum 
was applied to sections of lactating rat mammary gland that had been 
fixed in formalin for 18 hours. No increase in fluorescence was observed 
for the a-LA treated immune serum slide above the control normal rabbit 
. serum slide, although the untreated immune serum slide produced a net 
fluorescence of 3.0. This result demonstrated that excess pure rat a-LA 
would block all the specific fluorescence of the immune serum. 
None of the supernatant solutions from homogenized normal rat 
tissues produ·ced any displacement of counts in the rat a-LA RIA, indi-
cating that there is no general species cross-reactivity between rabbit 
antibodies and soluble rat proteinso To eliminate the possibility that· 
there might also have been tissue/species cross-reactivity, 1 ml samples 
of rabbit antirat a-LA serum and normal rabbit serum were incubated for 
30 minutes at room temperature with 100 mg of normal rat liver acetone 
powder (104), then centrifuged for 20 minutes at 30,000 x g at 4° C. 
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The supernatant solutions were compared with untreated immune serum 
and normal rabbit serum samples on sections of lactating rat mammary 
gland fixed in formalin for 18 hours. Identical fluorescence values 
were obtained for both the liver acetone powder treated and untreated 
immune serum (3.5) and normal rabbit serum slides (Oa5) producing a 
net fluorescence value of 3.0 for both the acetone powder treated slides 
and the untreated slides. This indicated that both the RIAs and the 
histochemical systems were specific for detection of a-LA. 
Human tissues were also examined in the same mariner for a-LA and 
y-globulin receptorso Two benign tumors were obtained and one was 
diagnosed as fibrocystic disease and the other as an adenoma. Six 
micron sections were cut from the frozen specimens. These were fixed 
in formalin for 5 minutes or 18 hours and washed in balanced salt 
until used. The three human test sera were diluted in the same manner 
as the rat test sera except male human sera was substituted for the 
male rat sera as the blocking y-globulins. As shown in Table XI, a-LA 
was demonstrable in both tissues, but at rather low levels. A decrease 
in fluorescence was seen with both chemical inactivation by formalin 
and with blocking of the receptor with human y-globulins. Because the 
levels of a-LA seemed to be lower in human tumors than in the rat 
model tumors, and because fresh frozen human tissue is difficult to 
obtain, a more sensitive system of detecting a-LA in situ that could 
be applied to paraffin sections was developeda 
Horseradish Peroxidase System 
Materials and Reagents 
Nonlabeled goat antirabbit y-globulin was purchased from Pentexa 
TABLE X I 




Patient DA NRS 
Fibrocystic Disease GARyg 
Net 
IS 
Patient LA NRS 
Adenoma GARyg 
Net 
IS - immune serum 
NRS - normal rabbit serum 
5·min NBF 5 min NBF 
Antiserum 
Antiserum Diluted in Male 









GARyg - goat antirabbit y-globulin. 
NBF - neutral buffered formalin 
18 h NBF 18 h NBF 
Antiserum 
Antiserum Diluted in Male 














Horseradish peroxidase type II, 3,3'-diaminobenzidine tetrahydrochlo-
ride, periodic acid, and sodium borohydride were purchased from Sigma. 
The 1-fluor-2,4-dinitrobenzene was purchased from Aldrich. Ethylene 
glycol and hydrogen peroxide were purchased from Matheson. The A 0.5 M 
chromatography gel was purchased from Bio-Rad. Formation of the diamino-
benzidine precipitate was evaluated with an Olympus microscope Model EHT, 
and photographs taken using the PM-10 photographic unito Tissue speci-
mens Were automatically processed through paraffin embedding by the 
Autotechnicon instrument. 
Methods 
The traditional method of coupling horseradish peroxidase to 
antibodies employed a bivalent coupling reagent, such as glutaralde-
hyde, to covalently attach the two proteins. Horseradish peroxidase 
and antibody were mixed with glutaraldehyde for several hours and the 
randomly coupled products were separated on molecular weight columns. 
This technique was subject to the major drawbacks of self-coupling of 
each protein to itself, and loss of biological activity by chemical 
modification of either or both proteinso 
The new procedure which was employed circumvented these problems 
by allowing only directed coupling of horseradish peroxidase to anti-
body molecules. This resulted in a very high correct coupling effi-
ciency, while retaining full biological activity of both proteins. 
This procedure, developed by Nakane and Kawoai (105), takes advantage 
of the glycoprotein nature of horseradish peroxidase which has a carbo-
hydrate content of 18%. In general terms, the first step blocks the 
free amino groups on horseradish peroxidase by reaction with fluorodi-
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nitrobenzene. Then the carbohydrate moities are oxidized with sodium 
periodate producing aldehyde groups which can be reacted unidirectionally 
with the free amino groups on the antibody moleculeso The resulting 
Schiff's base is stabilized further by reduction with sodium borohydride, 
and the active coupled product is purified by c~lumn chromatography. 
Specifically, 5 mg of horseradish peroxidase type II were dissolved in 
1 ml of 0.3 M NaHC03, pH 8.1, and 0.1 ml of 1% (v/v) fluorodinitrobenzene 
in absolute alcohol was added at room temperature with gentle stirring 
by a paper clip stirring bar. After reacting for 1 hour, 500 ~1 of 
0.12 M Nai04 in H20 were added and the mixture stirred for another hour 
at room temperature. To the resulting yellow-green solution, 500 ~1 of 
0.32 M ethylene glycol in H20 were added and stirred at room temperature 
for another hour. The solution was then dialyzed three times against 
a liter of 10 mM NaHC03, pH 9.5, at 4° C. The blocked and oxidized 
horseradish peroxidase was reacted with 5 mg of lyophilyzed goat anti-
rabbit y-globulin for 3 hours'at room temperature, and the resulting 
Schiff's base was stabilized by reduction with 5 mg of NaBH4 for 3 hours 
at 4° C. The solution was subsequently dialyzed against balanced salt 
solution overnight at 4° C, centrifuged at 30,000 x g for 10 minutes, 
and the supernatant solution was applied to the A 0.5 M molecular 
weight filtration column equilibrated with 0.1 M KCl, 50 mM phosphate, 
pH 7.4. One ml fractions were collected at a 4 s/drop rate and the 
protein elution profile determined by absorbancy at 280 nm. Horseradish 
peroxidase was detected by absorbancy at 403 nm. Samples were stored 
at -20° C with no loss of either biological activity. 
The system for detecting a-LA with the horseradish peroxidase 
coupled goat antirabbit y-globulin is based on the same principles as 
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the fluorescein labeled goat antirabbit y-globulin systemo Briefly, 
rabbit serum containing antibodies against the desired antigen is incu-
bated on a thin tissue section. A second goat serum containing horse-
radish peroxidase coupled antibodies directed against rabbit y-globulins 
localizes and amplifies the first antibodyo Addition of the substrates 
for horseradish peroxidase, diaminobenzidine and hydrogen peroxide, 
leads to the formation of a dark insoluble precipitate of oxidized 
diaminobenzidine which can be visualized by light microscopy. 
The proper controls for the system include a slide on which the 
anti-a.-LA serum is replaced by normal rabbit serum. This control slide 
detects binding of the rabbit y-globulins and cross-reactivity of tissue 
antigens between species. Another control slide has on1y the coupled 
goat antirabbit y-globulin serum and detects the same types of antibody 
binding as above which are not in response to a.-LA molecules. Because 
endogenous peroxidase activity can be found in mi1k and-red blood cells, 
a slide which has no y-globulin addition but is merely incubated in the 
substrate solution is also necessary. 
The detailed conditions for these experim~nts include preparation 
of the thin tissue sections. Since the product of the reaction of horse-
radish peroxidase with diaminobenzidine and hydrogen peroxide is visua-
lized by conventional light microscopy, the use of paraffin embedded 
thin sections is not excluded because a.-LA is not antigenically altered 
by the embedding procedure to such an extent that it can no longer be 
recognized by its antibodies. The paraffin embedding process dehydrates 
the tissue by successive passages at 25° C for 60 minutes each in 40%, 
80%, and 100% ethanol, then incubation in xylene, and finally_ perfusion 
with paraffin at 58° C for 60 m1nutes. To ensure good tissue preserva-
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tion through the embedding process, specimens were fixed in 10% neutral 
/ 
buffered formalin overnight before being submitted for automated paraffin 
embedding. All tissue specimens were then sectioned at 5 micron thick-
ness with a microtome, placed on glass slides and returned to the origi-
nal balanced salt phase by reversing the dehydrating sequence of solu-
tions used to embed in paraffin. The extended formalin fixation and the 
vigorous conditions of paraffin embedding helped to destroy the specific 
y-globulin receptor binding activity of mammary epithelial cells. How-
ever, the endogenous peroxidase-like activity of hemoglobin present in 
' red blood cells is not totally destroyed by formalin treatm~nt or par-
affin embedding. Attempts to inhibit the activity with cyanide or azide 
ions were unsuccessful. 
The rabbit anti-a-LA sera, and the normal rabbit serum were diluted 
I 
10 fold in balanced salt solution. The horseradish peroxidase coupled 
goat antirabbit y-globulin was diluted to an absorbance of 0.08 at 
280 nm. 
The incubation conditions are similar to the immunofluorescence 
system and all are performed at room temperature. The immune serum and 
normal rabbit serum slides were incubated with their respective serum 
for 30 minutes. The immune serum slide, the normal rabbit serum control 
slide, and the goat antirabbit serum control slide, were incubated for 
30 minutes with the horseradish peroxidase coupled goat antirabbit 
y-globulin serum and then washed for 30 minutes in balanced salt solu-
tion. These three slides, and the diaminobenzidine control slide were 
then incubated in a solution of 1.4 mM diaminobenzidine, 0.0003% hydro-
gen peroxide (v/v), in 50 mM Tris, pH 7.4 at room temperature for 30 
minutes then rinsed for 10 minutes in balanced salt solutions. Oxidized 
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diaminobenzidine forms an insoluble, dark brown precipitate which was 
visualized by conventional light microscopyo The intensity of the 
precipitate is rated to 0.5 units on an increasing unitless scale of 
0 to 8 by double blind evaluation of two investigators. The final 
values reported are the average of the two blind evaluations. 
Results 
Rat and human tissue were tested for a-LA with the horseradish 
peroxidase system as shown in Table XII. The lactating rat mammary 
gland was taken three days after parturition and served as the positive 
control for the rat tissueso Preservation of tissue and cellular 
morphology was excellent and large amounts of secretory products were 
still present in the lumina. The areas of precipitate deposition were 
restricted to the cells lining the ascini of the lobules, with the 
connective stroma devoid of any precipitate. Examination of the epithe-
lial cells with high magnification indicated only cytoplasmic precipi-
tate which was most intense at the apical border with the lumen. The 
secretory products in the lumina stained heavily indicating large 
amounts of a-LA were present. The diaminobenzidine control slide was 
negative, indicating that the endogenous lactoperoxidase activity which 
can react with these substrates, had been denatured by the formalin 
and embedding processes. The normal rabbit serum control slide was 
slightly positive which may indicate that a small amount of residual 
y-globulin receptor activity was still present after formalin fixation 
and paraffin embedding. The goat antirabbit y-globulin control slide 
was negative. This is consistent with the data from the immunofluores-
cence system which indicated that the rat y-globulin receptor on mammary 
TABLE XII 
EVALUATION OF a-LACTALBUMIN IN RAT AND HUMAN TISSUES 
BY THE HORSERADISH PEROXIDASE METHOD' 
Tissue Treatment IS NRS GARyg 
R3230 AC 18 h NBF 3.0 0.5 0.0 
R3230 AC 18 h NBF, p 3.0 0.5 0.0 
Rat Mammary Gland 18 h NBF, P 5.0 0.5 0.0 
13762 MAT/A 18 h NBF 0.5 0.5 0.0 
DA - Fibrocystic Disease 18hNBF,P 3.0 0.7 0.0 
CO - Breast Carcinoma 18 h NBF, P 1.5 0.7 0.0 
CO - Lymph Node Metastases 18 h NBF, p 1.0 0.5 0.0 
RO - Ovary Carcinoma 18 h NBF, P 0.7 0.5 0.5 
SW - Breast Carcinoma 18 h NBF, p 0.7 0.5 0.0 
LA - Adenoma 90 d NBF, p 0.7 0.2 0.0 
BT-20 Solid Tumor 18 h NBF, P 0.5 0.5 0.0 
BT-20 Cell Culture 18 h NBF 0.5 Q.5 0.0 
C0-2 Solid Tumor 18 h NBF, p 0.5 0.5 0.0 
CL-2 Solid Tumor 18 h NBF, p 0.5 0.5 0.0 
ST-2 Solid Tumor 18 h NBF, P 0.5 0.5 0.0 


















IS - immune serum GARyg - goat antirabbit y-globulin 
NRS - normal rabbit serum DAB - diaminobendizene 
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tissue does not recognize goat y-g1obulins. The net intensity of pre-
cipitate! formation for the colostrum lactating rat mammary gland was 
4.5. No other rat tissue was more positive. 
The small R3230 AC tumor taken 10 days after injection was treated 
by formalin fixation for 18 hours. The tissue was then divided and 
part was embedded in paraffin, sectioned, and then brought back to 
the water phase. The other half was frozen and also sectioned on a 
cryostat at 5 microns thickness. The sections treated by the two methods 
produced identical results which verifies the antigenic stability of 
a-LA through the paraffin embedding process. The net intensity of pre-
cipitate formation for the R3230 AC tumor was 2.5 w~ich is consistent 
with the high level of a-LA determined by the RIA. 
A peritoneal aspirate of the 13762 ascites MAT/A line was air-dried 
on slides and fixed in formalin for 18 hours then washed in balanced 
salt solution for one hour. No net precipitate formation was observed. 
This result may be a consequence of the increased molecular dimensions 
of the horseradish peroxidase goat antirabbit y-globulin complex which 
would decrease the antibody's ability to penetrate the cell's membrane. 
Some investigators have overcome this problem by splitting the anti-
body molecule and forming the smaller Fab-horseradish peroxidase complex 
which has better penetrating ability (106). 
Human tissue specimens were also analyzed for a-LA by the horserad-
ish peroxidase system. Frozen specimens were processed as described 
previously and evaluated for precipitate formation. The fibrocystic 
disease specimen from DA contained areas of epithelial cells which 
formed ascini that were arranged in lobular form. These regions were 
surrounded by large areas of fibrous stroma. The epithelial cells and 
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the substance contained in the small lumina were quite positive, while 
the stromal elements were negative. A higher background was noted on 
the normal rabbit serum control slide, indicating the tissue specimen 
may not have been totally permeated with formalin. The primary breast 
carcinoma from CO and the metastases present in the lymph node were 
both moderately positive, which supports the RIA data. The adenoma from 
LA had been in neutral buffered formalin for about three months before 
paraffin embedding and was judged only moderately positive, although 
the tissue contained tremendous numbers of ascini which were filled 
with secreted substances. Excessive formalin fixation, may cause impaired 
detection of a-LA. 
The mucinous ovary carcinoma of RO contained detectable levels of 
a-LA as determined by RIA. The horseradish peroxidase system confirmed 
the low levels of a-LA and reinforces the idea of ectopic production 
of proteins by some tumors (107). The cells lining the very large cysts 
were weakly positive, but the mucinous material filling the large cysts 
was essentially negative. The other breast carcinoma from SW was also 
weakly positive with only the epithelial cells of the ascini containing 
precipitate. 
The second group of tumors produced in the nude mouse by subcu-
taneous injection of the human cell lines obtained by pleural effusion 
were also examined. None of the tissues were judged to be a-LA positive, 
which is in support of the RIA data. Hematoxylin and eosin stained 
paraffin sections of the nude mouse tumors reve~led an extremely neo-
plastic condition with extensive pleomophism. No suggestive patterns 
of ascinar formation could be found. Slides were also prepared with 
the BT-20 cells and placed in neutral buffered formalin for 18 hours. 
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These cells which were grown in vitro culturing were also negative for 
a-LA. 
Photomicrographs of lactating rat mammary gland treated by the 
horseradish peroxidase system for a-LA detection are shown in Figure 20. 
The immune serum slide shows areas of heavy precipitate deposition while 
the cqntrol normal rabbit serum slide is free from precipitate. 
Figure 20. Photomicrographs of Lactating Rat Mammary Gland Using the 
Horseradish Peroxidase Method for Detection of Rat 
a-Lactalbumin 
Sections of lactating rat mammary gland were fixed in neutral buffered 
formalin for 12 hours and then were embedded in paraffin. Sections 
five microns thick were cut and returned to the water phase. The 
top panel is tissue treated with rabbit antirat a-LA serum followed 
by peroxidase coupled goat antirabbit y-globulins and then reacted 
with diaminobenzidine. The bottom panel is tissue treated with 
normal rabbit serum followed by peroxidase coupled goat antirabbit 
y-globulins and then reacted with diaminobenzidine. (Methods). 
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CHAPTER VII 
GAMMA GLOBULIN RECEPTORS OF MAMMARY 
EPITHELIAL CELLS 
Materials and Reagents 
Bovine y-globulin, Cohn Fraction II (108) with electrophoretic 
purity greater than 99% and fluorescein isothiocyanate isomer I, were 
purchased from Sigma. The y-globulin fraction of pooled normal human 
plasma from venous blood was purchased from Hyland. 
Methods 
Rat and rabbit y-globulins were purified from pooled normal serum 
by the procedure of Heide and Schwick (109). Blood was collected from 
the animals and allowed to totally clot at 4° C overnight, then centri-
fuged at 5000 x g for 20 minutes at 4° C to collect the serum. Per-
forming all steps at 4° C, the supernatant solution was made 35% 
(19.4 g/100 ml) saturated with ammonium sulfate and the precipitate 
was collected by centrifugation at 30,000 x g for 10 minutes. The pellet 
was resuspended in the original volumn with 20 mr1 Tris, pH 7.4 and the 
solution precipitated with ammonium sulfate and centrifuged as before. 
This procedure was performed a total of four times, and the final pellet 
. was resuspended in 20 mM Tris, pH 7.4 and dialyzed exhaustively against 
deionized water. The dialyzed solution was centrifuged at 30,000 x g 
for 20 minutes and the supernatant solution analyzed for purity by 
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discontinuous acrylamide gel electrophoresis as described previously, 
and by quantitative serum analysis with cellulose acetate strips (91). 
Both systems indicated the commercial human and bovine y-globulins had 
greater than 99% purity. The rabbit and rat y-globulins prepared by 
the above procedure contained greater than 96% y-globulins with 2% 
s-globulins and 2% a2-globulins. No serum albumin could be detected 
in any y-globulin sample. 
The purified y-globulin fractions were conjugated with fluorescein 
i sot hi ocyanate by the method of Marsha 11 et ~- ( ll 0). The y-gl obul in 
fractions were suspended in 15 mM NaCl, 50 mM NaHC03, pH 9 to a final 
protein concentration of 10 mg/ml. Performing all steps at 4° C, 50 llg 
of fluorescein isothiocyanate were added for each milligram of y-globu-
lin, and the solution gently stirred for 18 hours. The conjugated 
y-globulin fraction was again made to 35% (19.4 g/100 ml) saturation 
with ammonium sulfate and the precipitate collected by centrifugation 
at 30,000 x g for 10 minutes and resuspended in the original volume with 
20 mM Tris, pH 7.4. This procedure was repeated a total of four times. 
The final pellet was resusp~nded at a 16 mg/ml level with 10 mM phos-
phate, 0.14 M NcCl, 4 mM KCl, pH 7 and dialyzed extensively against the 
resuspending buffer until the dialysate was visually frre of fluores-
cence when exposed to ultraviolet light. The dialyzed solution was 
centrifuged at 30,000 x g for 20 minutes and the supernatant solution 
stored at -20° C. 
Tissue samples were prepared by quickly freezing the excised tissue 
specimens in liquid nitrogen, then cutting sections as thinly as possible 
with the -20° C cyrostat. The tumor sections were cut at 5 microns and 
the lactating rat and rabbit mammary glands were cut at 12 microns. The 
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tissue sections were air-dried on the slides at room temperatur~ for 
30 minutes, and then placed in 10% neutral buffered formalin solution 
(10% (v/v) formaldehyde, 50 mM phosphate, pH 7.0) for 5 minutes or 
18 hours at room temperature. The sections ·were washed in balanced 
salt solution (0.14 M NaCl, 4 mM KCl, 0.5 mM Na2HP04, 0.17 mM NaH2Po4, 
pH 7.2) for one hour and then used in the experiments. 
The objectives of the following experiments were (1) to demonstrate 
/ 
the presence of y-globulin receptors on mammary epithelial cells and 
(2) to determine the ability of these receptors to recognize y-globulins 
from other species. Performing the experimental procedure at room 
temperature, sections from a particular tissue were incubated for one 
hour with solutions of its fluorescein labeled y-globulin which were 
diluted with a 50 fold greater level of unlabeled y-globulins from the 
other species. The slides were washed for one hour in balanced salt 
solution, mounted in glycerin and judged by double blind evaluation of 
two investigators on the Zeiss ultraviolet microscope using an increas-
ing unitless scale of 0 to 8. For example, 3 day lactating rat mammary 
gland was removed, frozen, sectioned, and fixed as described. The fluo~ 
rescein labeled rat y-globulins were diluted 10 fold with 0.1 M KCl, 
20 mM Tris, pH 7.4 containing 0.1% (w/v) bovine serum albumin. The 
solution was, therefore, 1 mg fluorescein labeled rat y-globulin/ml and 
1 mg bovine serum albumin/ml. The fluorescein labeled rat y-·globulins 
were also diluted 10 fold with purified unlabeled y-globulins from 
othe.r species at 50 mg y-globul ins/ml in 0.1 M KCl, 20 mM Tris, pH 7.4 
containing 0.1% bovine serum albumin. Five slides were incubated for 
one hour at room temperature with the rat fluorescein labeled y-globulins 
diluted with the buffer only, or the buffer with excess unlabeled rat, 
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rabbit, human, or bovine y-globulins. The slides were then washed for 
one hour in balanced salt solution, mounted, and evaluated as described 
before. For each different tissue the same basic procedure used. For 
example, when examining the rabbit lactating mammary gland, the fluores-
cein labeled rabbit y-globulins were diluted 10 fold with the buffer or 
with the buffer containing 50 fold greater concentration of unlabeled 
rabbit, rat, human, or bovine y-globulins. 
Results 
Three rat mammary tissues were analyzed for the presence and speci-
ficity of they-globulin receptors. As shown in Table XIII, the colos-
trum lactating rat mammary gland had a high level of y-globulin receptors 
as indicated by the 3.3 net displacement of fluorescence between the 
slides incubated with and without excess unlabeled rat y-globulins. As 
predicted by the previous immunofluorescence data, rabbit y-globulins 
were also successful in binding to they-globulin receptors and produced 
a displacement value of 3.0. Unlabeled bovine and human y-globulin 
were not very effective competitors with rat y-globulins for the rat 
mammary gland y-globulin receptors. They produced displacement values 
of only 1.0 and 1.3 respectively. This also supports the data from 
the previous fluorescence study where bovine y-globulins were not effec-
tive at reducing the fluorescence of the normal rabbit serum control 
slide. 
The R3230 AC adenocarcinoma indicated a slightly higher level of 
y-globulin receptors than the lactating mammary gland with the same 
trends of displacement by y-globulins from other species. However, the 
differences between the values for displacement by unlabeled y-globulins 
TABLE XIII 
EVALUATION OF y-GLOBULIN BINDING TO MAMMARY EPITHELIAL CELLS OF THREE SPECIES 
FL"-Rat-yg___ FL-Ratyg --FL-Rat yg Ft..-Rat yg FL-Rat yg 
Rat Tissue +·Rat yg + Rabbit yg + Bovine yg __ ± Hum~n yg Auto 






















Human Tissue + Rat yg + Rabbit xg + Bovine yg + Human yg Auto 
CO - Breast Carcinoma 
CO - Lymph Node Metastases 
DA - Fibrocystic Disease 
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from the different species was not as dramatic as for the lactating 
mammary gland. The ascites 13762 MAT/A line cells had rather low levels 
of y-globulin receptors with the same trends seen for the lactating 
mammary gland. Again however, there was not a large difference between 
the displacement values for unlabeled y-globulins from the other species. 
This increased degeneracy of they-globulin receptors of malignant 
mammary tissue may be a reflection of the malignant process. 
Human tissues were also investigated and the epithelial cells of 
the various mammary diseases possessed y-globulin receptors. The ability 
of they-globulin receptors to recognize y-globulins from other species 
was generally reversed from the rat mammary tissues. The excess rat and 
rabbit unlabeled y-globulins were not as effective in competing for the 
y-globulin receptors as were the bovine and human y-globulins. However, 
the trends were not always unequivocal and more tissues should be exam-
ined to determine if a general trend is apparent. 
Rabbit lactating mammary gland was investigated and it contained a 
very high level of y-globulin receptors. The data indicated these recep-
tors recognize rabbit and human y-globulins equally well and also have 
rather good ability to recognize rat and bovine y-globulins. 
To ensure that the test system was not subject to large nonspecific 
protein binding effects, the following experiment was performed. The 
colostrum forming rat mammary gland sections were incubated with solu-
tions of fluorescein labeled rat y-globulins that were diluted 10 fold 
in 0.1 M KCl, 20 mM Tris, pH 7.4 containing bovine serum albumin at 
different levels. As shown in Table XIV, incubation of the fluorescein 
labeled rat y-globulin in solutions of 0 to 5% (w/v) bovine serum albu-
min did not cause any detectable decrease of fluorescence. This suggests 
TABLE XIV 
EFFECT OF BOVINE SERUM ALBUMIN ON y-GLOBULIN BINDING 
TO RAT MAMMARY EPITHELIAL CELLS 
mg/ml of Bovine Serum 
Albumin with Fluorescein 


















that there is essentially no nonspecific binding of the y-globulin to 
mammary epithelial cells, and that the observed fluorescence is due to 
specific and selective binding of y-globulins. Further, in no tissue 
did the supporting stroma take part in the specific binding of y-globu-
lins. The fluorescence was limited to the epithelial cells lining the 
ducts. 
CHAPTER VI II 
DISCUSSION AND SU~1MARY 
To date, the biochemical level of differentiation of breast tumors 
has not been investigated using a reliable marker protein that is hor-
monally controlled and specific for mammary epithelial cells. Because 
the enzymatic measurements of a-LA is often prohibited by competing 
enzyme systems, radioimmunoassays for human and rat a-LA were developed. 
This required ultrapure a-LA which was obtained by a modification of the 
Schmidt (89) procedure. By performing two ammonium sulfate precipita-
tion steps instead of one, more contaminating proteins were removed early 
in the purification. Removal of the casein micelles by centrifugation 
at 100,000 x g for one hour proved satisfactory. The P-150 column 
was very effective at resolving the a-LA activity from the remaining 
higher molecular weight contaminants. The DEAE-32 column removed the 
remaining minor contaminant and pure human a-LA was obtained. Antisera 
to rat a-LA and human a-LA were prepared from rabbits and their titers 
were exceptionally high. Double diffusion analysis for cross-reactivity 
of both antisera indicated that antirat a-LA antibodies did not cross- I 
react with any other a-LA except human. The antihuman a-LA antibodies 
displayed a time dependent cross-reactivity to a-LAs from other species 
which was absent in sera drawn three weeks after injection but present 
in sera drawn five weeks after injection. The monospecific nature of 
the antisera was demonstrated by a single band in double diffusion tests 
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against their whey fraction. Also, immunoelectrophoresis against the 
pure a.-LA and their whey fraction produced a single band with antihuman 
a.-LA serum and a spurred band for antirat a.-LA serum. This observation 
for rat a.-LA is a reflection of the known charge isomers of rat a.-LA. 
The optimal conditions for both RIAs were determined. a.-Lactalbumin 
with a specific activity of about 80 ~Ci/~g is required and can be 
obtained by the iodochloride method, chloramin-T method, or lactoperoxi-
·dase method. Free and antibody bound 125I•a-LA are quantitatively 
and efficiently separated by using polyethylene glycol precipita-
tion of they-globulin a.-LA complex which can be colles:ted by filtra-
tion on 0.45 ~ cellulose acetate filters. The effects of pH, ionic 
strength, and protein on the RIAs were investigated and optimized condi-
tions were ':determined to be pH 7 .4, 0.1 M KCl, and 0.1% bovine serum 
albumin. It is important to note that protein levels greater than 
10 mg/ml can cause false positive values of a-LA. Samples must meet 
the requirements of pH between 6 and 8.5, ionic strength between 4 and 
22 m mho, and protein concentration between 1 and 10 mg/ml to achieve 
reliable answers. The temperature and sequence of addition of reactants 
to the RIAs can increase the limit of detection about two times. This 
was accomplished by incubation at 4° C and sequential addition of anti-
serum and unlabeled a.-LA with 12 hours of incubation followed by 
1251-a.-LA addition and 12 hours additional incubation. These techniques 
generated standard curves with limits of detection at 30 pg a-LA in the 
assay or 0.3 pg a-LA/119 and 75 pg a.-LA/ml. There was no displacement by 
homogenates of normal rat tissues or normal human tissues in the RIAs. 
Rat model tumors for human neoplasms were analyzed for a-LA and a 
wide range of levels was found. The group of tumors histologically 
designated as adenocarcinomas ranged from 1.21 ng a-LA/~g protein to 
0.096 ng a-LA/].lg protein. While the SMT-2A breast carcinoma had 
0.0084 ng a-LA/~g protein yet was described histologically as poorly 
differentiated. This indicates that estimation of differentiation 
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by visual examination of tissue sections cannot reliably distinguish 
tissues except in some of the extreme --examples. The three ascites 1 ines 
still retained the ability to synthesize a-LA although at lower levels 
than the parent tumor. This may be a reflection of the growth condi-
tions inherent with the ascitic state and should be kept in mind when 
comparisons are made to the biochemical status of normal mammary cells. 
Sera from rats bearing tumors were analyzed and a correlation 
was found between the tumor size, as measured by the time after trans-
plantation, and the serum level of a-LA. The 13762 ascites MAT/A 
line produced detectable levels almost immediately and eventually rose 
to about 100 ng a-LA/ml serum at about ten days. The R3230 AC tumor 
had undetectable levels until about two weeks after transplantation. 
Then serum a-LA levels began to rise and eventually reached near 
lactating serum levels of about 300 ng a-LA/ml serum. The quick rise 
of a-LA in the sera from rats bearing the ascites line is probably due 
to the immediate growth of the injected cells and the rapid equili-
brium of compounds in the peritoneal cavity with the general body 
circulation. The transplanted R3230 AC tumor, on the other hand, does 
not develop palpable tumor masses until about seven to ten days after 
transplantation. This initially inhibited growth rate probably is 
due to an immunological response of the host, which is eventually 
overcome by the tumor and then a-LA appears in the blood. These observa-
tions suggest that it would be theoretically possible to detect and 
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monitor mammary tumors by analysis of serum for a-LA. 
To estimate the percentage of human breast carcinomas that syn-
thesize a-LA and their range of values, ten breast carcinomas were 
analyzed. Seven were found to contain detectable levels with a range 
of 0.4 to 22.0 pg a-LA/J.!g protein. Two cases of metastases to the 
associated lymph node from primary tumor positive for a-LA were ana-
lyzed and both synthesized a-LA at levels near or exceeding the parent 
tumor. These data suggest that the metastasized cells still retain 
the original level of differentiation of the parent tumor cells. 
Seven cases of benign fibrocystic/fibroadenoma disease were 
analyzed and all seven were positive for a-LA. Several reached very 
high levels of a-LA, the range being from 116 to 1.3 pg a-LA/J.!g pro-
tein. This observation would indicate the fibrocystic/fibroadenoma 
disease should generally be considered as a more differentiated disease 
state than a valid carcinoma. Since current theories consider cancer 
as a dedifferentiation process, these diseases could be considered as 
candidates for valid precancerous states. 
Analysis of malignant tumors from the lung and pancreas were 
negative for a-LA, as were the benign myelofibrosis of the spleen and 
the male gynecomastia. One case of an ovary carcinoma contained a-LA. 
This probably is due to ectopic production of a-LA. 
Presurgery sera from breast carcinoma patients were assayed and 
10 of the 35 had detectable levels of a-LA which had an average value 
of 10.2 ng a-LA/ml serum. All of the postsurgery sera from the patients 
with positive presurgery were 0.0, indicating removal of the tumor 
removed the source of a-LA production. All control male and female 
sera were also 0.0. These data s4ggest that an abnormal level of serum 
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'a-LA may indicate a breast lesion. These values are low compared to the 
levels reported in the rat tumor system and are probably due to the very 
large size of the rat tumors compared to the total body weight. In 
humans, a tumor would probably be detected by conventional means before 
it reached the proportional size obtained in rats. The work of Kleinberg 
(67) indicated only 5 of 44 patients with metastatic breast carcinoma 
had detectable levels of serum a-LA with a range of 1 to 12 ng a-LA/ml 
and a mean value of 6 ng a-LA/ml. In addition he also reports 9 of 22 
normal males and 15 of 33 normal females had serum a-LA levels with mean 
values of 5.83 ng a-LA/ml and 6.42 ng a-LA/ml respectively. It is 
difficult to accept that a-LA could appear in the serum of men even with 
gynecomastia. Hendrick and Franchimont (73) have reported that casein 
is found in the sera of 80 percent of patients with metastatic breast 
carcinoma. However, their levels are 1000 times greater than the levels 
of a-LA reported here. Also, they reported high levels of casein in 
sera from patients with lung and gastric cancers. Most significantly, 
1 
they have been unable to establish any correlation between the presence 
of casein in the serum and the histological nature of the tumor. In 
view of the polymorphism of human caseins, they probably are not a 
reliable marker antigen for human mammary dysplasia. 
Because the serum levels of a-LA from presurgery breast cancer 
patients were low, it was of interest to determine the rate of clearance 
of a-LA from blood. The half life was determined to be 3.5 hours which 
is longer than polypeptide hormones like insulin, which has a 1.5 hour 
half life (111), but shorter than normal serum proteins like transferrin 
which has a half life of 7 to 10 days (112) or immunoglobulin G which 
has a half life of 18 to 23 days, or immunoglobulin E which has a half 
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life of 2 to 4 days (113). This rapid clearance of even large levels 
(6 mg) ot a-LA probably helps to maintain very low blood levels 
except in periods of relatively intense secretion. The clearance 
rate from blood for caseins has not been determined and would be of 
interest in view of the high levels reported in sera from breast 
carcinomas. 
The organs primarily responsible for clearance of a-LA from 
blood are the liver and lungs, with a large contribution by capillary 
beds such as found in muscle. Because no increase in trichloracetic 
acid soluble material appears after injection of labeled a-LA, there 
probably is no ili1nediate degradation with release of fragments to the 
serum. 
Purported human mammary carcinoma cell lines obtained by pleural 
effusion were assayed for a-LA and all were negative, even if injected 
into athymic mice and regrown as solid tumors. These results raise 
serious questions as to the validity of assuming that the cells com-
prising a pleural effusion of a breast carcinoma contain malignant dif-
ferentiated mammary cells. The question must be asked whether the cells 
have lost the ability to make specialized milk proteins as a conse-
quence of cell culturing conditions, or whether the original cell po~u­
lation ever contained differentiated mammary cells at the start of 
culturing. One report (65) claims to have successfully cultured a 
pleural effusion from a mammary carcinoma that synthesized 0.155 ng 
a-LA/~g protein, which is significantly higher than the levels of the 
rat 13762 ascites lines (0.02 ng a-LA/~g protein). 
Two methods for detecting a-LA in situ were developed: the immuno-
fluorescence system and the horseradish peroxidase system. These methods 
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qualitatively confirmed the RIA results. Paraffin embedded tissue 
sections developed severe autofluorescence, which restricted immuno-
fluorescence studies to fresh frozen samples. The horseradish peroxi-
dase method, however, worked best on paraffin embedded tissue samples. 
Cases from the surgical pathology files were investigated in an effort 
to determine whether certain diseases were actually related to breast 
cancer, and to determine their. degree of differentiation. 
Areas of ce 11 s within tumors were judged by immunofluorescence to 
produce different level~ of a-LA, indicating that tumors probably con~ 
tain populations of cells with varying levels of differentiation. 
Homogenization would indicate an average value of a-LA production for 
a particular area of a tumor. Bussolati and Pich (78) analyzed human 
breast diseases for caseins using immunofluorescence and peroxidase 
methods. Their data indicated most breast carcinomas produced caseins; 
however, the sebaceous glands also stained. This may be a reflection 
' 
of endogenous peroxidase activity and should be clarified before valid 
/ 
conclusions could be drawne The use of casein as the antigen marker 
for histochemical studies suffers from the same drawbacks as mentioned 
before. 
In the course of developing the immunofluorescence system, speci-
fie y-globulin receptors were detected on mammary epithelial cells. 
These receptors could be bl?cked by y-globulins to which the fluores-
cein labeled goat antirabbit y-globulins did not cross-react. Also 
\ 
they could be chemically modified by formalin fixation which resulted 
in the loss of their biological activity. By directly labeling purified 
y-globulins with fluorescein and incubating them with excess unlabeled 
y-globulins, it was possible to determine the degeneracy of the y-globu-
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lin receptors on mammary epithelial cells from different species. The 
y-globulin receptors of rat mammary tissue effectively recognized only 
rat and rabbit y-globulins. They-globulin receptors of human and 
rabbit mammary tissue recognized both human and rabbit y-globulins with 
substantial binding of the bovine and rat y-globulins also. 
These data would indicate that clinical diagnosis of breast diseases 
could be aided by serum analysis and determination of the lesion's 
degree of differentiation. All of the purported human mammary cell 
lines that were assayed did not contain detectable levels of a-LA, 
and the validity of the pleural effusion technique should probably be 
re-evaluated. The use of the horseradish peroxidase technique for 
detecting a-LA has opened tissue files of pathology departments for 
examination of large numbers of disease states. Further investigation 
on the specificity of y-globulin receptors of normal and malignant 
states may lead to a clinically applicable method of selecting malig-
nant cells in vivo. 
REFERENCES 
1. Cairns, J. (1975) Sci. American 233, 64-75 
2. McKenzie, L., Fitzgerald, D. K., and Ebn~r, K. E. (1971) Biochim. 
Biophys. Acta 230, 526-530 
3. Brodbeck, U., and Ebner, K. E. (1966) J. Biol. Chern. 241, 762-764 
4. Nelson-Rees, W. A., Flandermeyer, R. R., and Hawthorne, P. K. 
(1974) Science 184, 10~3-1096 
5. Goss, R. J. (1967) in Control of Cellular Growth in the Adult 
Organism (Teir, H., and Rytomaa, T., eds) pp. 3-5, Academic 
Press, New York 
6. Turkington, R. W. (1968) Endocrinology 82, 540-546 
7. Majumder, G. C., and Turkington, R. W. (1971) Endocrinology 88, 
1506-1510 
8. Tur,kington, R. W. (1971) in Biochemical Actions of Hormones Vol 2, 
pp. 55-80, Academic Press, New York 
9. Turkington, R. W., and Hilf, R. (1968) Science 160, 1457-1459 
10. Baird, D. J. (1968) J. Clin. Endocrinol. Metab. 28, 244-249 
ll. Korenman, S. G., Perrin, L. E., and McCallum, T. P. (1969) J. Clin. 
Endocrinol. Metab. 29, 879-881 
12. Turkington, R. W., and Spielvogel, R. L. (1971) J. Biol. Chern. 246, 
3835-3840 
13·. Turkington, R. W. (1969) N. Y. State Med. J. 69, 2649-2655 










R. W. (1968) Endocrinology 82, 575-583 
R. w. (1969) Exp. Cell Res. 57, 79-85 
R. W. (1970) Cancer Res. 30, 1841 ... 1845 
R. W., Brew, K., Vanaman, T. C., and Hill, R. L. 
J. Biol. Chern. 243, 3382-3387 
131 
132 
19. Turkington, R. W., and Hill, R. L. (1969) Science 163, 1458-1460 
20. Turkington, R. W., Juergens, W. G., and Topper, Y. J. (1965) 
Biochim. Biophys. Acta 111, 573-576 
21. Lockwood, D. H., Turkington, R. W., and Topper, Y. J. (1966) 
Biochim. Biophys. Acta 130, 493-501 
22. Turkington, R. W., and Topper, Y. J. (1966
11
) Endocrinology 79, 
175-181 
23. Turkington, R. W., and Topper, Y. J. (1967) Endocrinology 80, 
1139-1142 
24. Turkington, R. W. (1970) J. Biol. Chern. 245, 6690-6697 
25. Turkington, R. W., and Riddle, M. (1969) J. Biol. Chern. 244, 
'6040-'6047 
26 •. Turkington, R. W., and Ward, 0. T. (169) Biochim. Biophys. Acta 
'174, 282-290 
27. Turkington, R. W. (1970) Biochim. Biophys. Acta 231, 484-494 
28. Turkington, R. W., and Self, D. S. (1970) Cancer Res. 30, 
1833-1840 
29. Marzluff, W. F., McCarty, K. s., and Turkington, R. W. (1969) 
Biochim. Biophys. Acta 190, 517-526 
30. Gilmour, R. S., and Paul, J. (1969) J. Mol. Biol. 40, 137-138 
31. Kadohama, N., and Turkington, R. W. (1973) Cancer Res. 33, 
1194-1201 
32. Kadohama, N., and Turkington, R. W. (1973) Can. J. Biochem. ~, 
1167-1176 
33. Turkington, R. W. (1971) J. Clin. Endocrinol. Metab. 33, 210-216 
34. Frantz, W. L., and Turkington, R. W. (1972) Endocrinology 91, 
1545-1546 
35. Leake, R. E., Mayne, R., and Barry, J. M. (1968) Biochem. Biophys. 
·Res. Coll1llun. 41 , 1290-1291 
36. Shiu, R. P. C., and Friesen, H. G. (1974) Biochem. J. 140' 301-311 
37. Chomczynski, P., and Topper, Y. J. (1974) Biochem. Biophys. Res. 
Commun. 60, 56-63 
38. Majumder, G. c., and Turkington, R. W. (1 971) J. Biol. Chern. 246, 
2650-2657 
133 
39. Majumder, G. C., and Turkington, R. W. (1971) J. Biol. Chern. 246, 
5545-5554 
40. Majumder, G. C., and Turkington, R. W. ( 1972) J. Biol. Chern. 247, 
7207-7217 
41. Turkington, R. W., and Riddle, M. (1970) J. Bi o l. Chern. 245, 
5145-5152 
42. Temin, H. M. (1974) Cancer 34, 1347-1352 
43. Kleiri, G., Giovanella, B., Lindahl, T., Fialkow. P., Singh, S., 
and Stehlin, J. (1974) Proc. Natl. Acad. Sci. U. S. A. 71, 
4737-4741 
44. Knox, W. E. (1974) Cancer Res. 34, 2102-2108 
45. Davidson, R., and Britten, R. (1974) Cancer Res. 34, 2034-2043 
46. Britten, R., and Davidson, E. (1969) Science 165, 349-357 
47. Gold, P., and Freedman, S. (1965) J. Exp. Med. 121, 439-442 
48. Gold, P., and Freedman, S. (1965) J. Exp. Med. 122, 467-481 
49. Dykes, P., and King, J. (1972) Gut }1, 1000-1013 
50. Ravry, M., Mcintire, K., Moertel, G., Waldmann, T., Schutt, A., 
and Go, V. (1974) J. Natl. Can. Inst. 52, 1019-1021 
51. Hilf, R., Michel, I., Bell, C., Freeman, J., and Borman, A. (1965) 
Cancer Res. 25, 286-299 
52. Turkington, R. W., and Riddle, M. (1969) Endocrinology 84, 
1213-1217 
53. Turkington, R. W., and Riddle, M. (1970) Cancer Res. 30, 127-132 
54. McGuire, W. L., Julian, J., and Chamness, G. (1971) Endocrinology 
89, 969-973 
55. 0 1Malley, B., and Means, A. R. (1974) Science 183, 610-611 
56. 0 1Malley, B. W., Spelsberg, T. C., Schrader, W. T., Chytil, F., 
and Steggles, A. W. (1972) Nature 235, 141-142 
57. McGuire, w. L., and Julian, J. (1971) Cancer Res. 31 ' 1440-1445 
58. McGuire, w. L. (1969) Science 165, 1013-1014 
59. McGuire, W. L., Costlow, M. E., and Buschow, R. A. (1974) Science 
184 . _, 85-86 
60. Yalow, R. S., and Berson, S. A. (1959) Nature 184, 1648-1649 
134 
61. Fitzgerald, D. K., Colvin, B., Mawal, R., and Ebner, K. E. (1970) 
Anal. Biochem. 36, 43-47 
62. Decker, Kq and Bischoff, E. (1972) FEBS Lett. 21, 95-97 
63. Geren, L., and Ebner, K. (1974) Biochem. Biophys. Res. Commun. 
59, 14-21 
64. Beck, N. F. G., and Tucker, H. A. (1974) J. Dairy Sci. 57, 604-605 
65. Rose, H. N., and McGarth, C. M. (1975) Science 190, 673-674 
/ 
66. Brooks~ s. c., Locke, E. R., and Soule, H. D. (1973) J. Biol. 
Chern. 248, 6251-6257 
67. Kleinberg., D. S. (1975) Science 190, 276-278 
68. Thompson, M. P., and Farrell, H. M. (1974) in Lactation A Compre-
hensive Treatise (Larson, B. L., and Smith, V. R., eds) Vol 3, 
pp. 109-134, Academic Press, New York 
69. Thompson, M. P. (1970) J. Dairy Sci. 53, 1341..;1380 
70. Farrell, H. M., and Thompson, M.P. (1971) J. Dairy Sci. 54, 
1219-1224 
71. Groves, M. L., Gordon, W. G., Kalan, E. B., and Jones, S. B. 
(1973) J. Dairy Sci. 56, 558-570 · 
72. Mackinlay, A. G., and Wake, R. G. (1971) in Milk Proteins 
(McKenzie, H. A., ed) Vol 2, pp. 175-215, Academic Press, 
New York 
73. Hendrick, J. C., and Franchimont, P. (1974) Eur. J. Cancer~' 
725-730 . 
74. Groves, M. L. and Gordon, W. G. (1970) Arch. Biochem. Biophys. 
140, 47-51 
75. Rumke, P. H., Bisser, D., Kwa, A. G., and Hart, A. A. (1971) 
.Folia Med. Neerl. 14, 156-158 
- 76. Coons, A. H. (1959) Pathol. Bacterial. 693, 700~702 
77. Bussolati~ G., Pich, A. and Alfani, V. (1975) Virchows Arch. Path. 
Anat. Histol. 365, 15-21 
78. Bussolati, G., and Pich, A. (1975) Am. J. Pathol. 80, 117-124 
79. Twarog, J. M., and Larson, B. L. (1962) Exp. Cell Res. 28, 350-359 
80. Turkington, R. W. (1969) Exp. Cell Res. 58, 296-302 
81. Kemler, R., Massmann, H., Strohmaier, U., Kickhofen, B., and 
Hammer, D. K. (1975) Eur. J. Immunol. _§, 603-608 
135 
82. Butler, J. E. (1974) in Lactation A Comprehensive Treatise 
(Larson, B. L., and Smith, V. R., eds) Vol 3, pp. 217-255, 
Academic Press, New York 
83. Gel Chromatography, Bio-Rad Laboratories, Richmond, California 
84. Whatman Advanced Ion Exchange Celluloses, Whatman Laboratories, 
Reeve Angle and Co. Ltd., London 
85. Davis, B. J. (1964) Ann. N. Y. Acad. Sci. 121, "404-409 
86. Weber, K., and Osborn, M. (1969} J. Biol. Chern. 244, 4406-4412 
87. Neville, D.- M. (1971) J. Biol. Chern. 246, 6328-6334 
88. McFarland, E. C. (1972) M. S. thesis, Department of Biochemistry, 
Oklahoma State University 
89. Schmidt,.V. D., and Ebner, K. E. (1971) Biochim. Biophys. Acta 
229, 407-411 
90. Brown, R. c. (1975) M. S. thesis, Department of Biochemistry, 
Oklahoma State University 
91. Gelman Clinical Electrophoresis Manual, No~ 62095, Gelman Instru-
ment Co.~ Ann Arbor, Michigan 
92. Prieels, J., Poortmans, J., Dolmans, M., and Leonis, J. (1975) 
Eur. J. Biochem. 50, 523-527 
93. Izzo, J. L., Bale, W. F., Izzo, M. J., and Roncone, A. (1964) 
J. Bio~. Chern. 239, .3743-3748 
94. Lee, C. Y., and Ryan, R. (1972) Proc. Natl. Acad. Sci. U. S. A. 
69, 3520-3523 
95. Thorell, J. I., and Johansson, B. J. (1971) Biochim. Biophys. Acta 
251, 363-365 
96. Eldridge, J. S., and Crowther, P. (1964) Nucleonics 22, 56-59 
97. Viol, G. W., Keane, P.M., Speed, J., and Smith, E. K. (1972) 
Clin. Biochem. 2, 251~65 
98. Schroeder, B.-T. (1973) Ph. D. thesis, Department of Biochemistry, 
Oklahoma State University 
99. Hartree, E. F. (1972) Anal. Biochem. 48, 422-427 
100. Bogden, A. E. {1976) Cancer Res. in press 
136 
101. Ebner, K. E., and McKenzie, L. M. (1972) Biochem. Biophys. Res. 
Commun. 49, 1624-1630 
102. Amicon Technical Data, Publication No. 441A, Amicon Corporation, 
Lexington, Massachusetts 
103. Guyton, A. C. (1971) in Textbook of Medical Physiology 4th Ed, 
pp. 393-404, W. B. Saunders Co., Philadelphia 
104. Tsai, C. M., Holmberg, N., and Ebner, K. E. (1970) Arch. Biochem. 
143, 579-586 
105. Nakane, P. K., and Kawaoi, A. (1974) J. Histochem. Cytochem. 22, 
1084-1091 
106. Lin, C. T., and Chang, J. P. (1975) Science 190, 465-467 
107. Turkington, R. W. (1971) N. Engl. J. Med. 285, 1455-1458 
108. Cohn, E. J., and Ferry, J.D. (1943) in Proteins, Amino Acids, 
and Peptides (Cohn, E. J., and Edsall, J. T., eds) pp. 586-
622, Reinhold Publishing Corp., New York 
109. Heide, K., and Schwich, H. G. (1973) in Immunochemistry (Weir, 
D. M., ed) pp. 61-71, Blackwell Scientific, New York 
110. Marshall, J. D., Eveland, W. E., and Smith, C. W. (1958) Proc. 
Soc. Exp. Biol. Med. 98, 898-900 
111. Williams, R. R., Gleason, R. E., and Soeldner, J. S. (1968) 
Metabolism lZ, 1025-1029 
112. Katz, J. H. (1961) J. Clin. Invest. 40, 2143-2146 
113. Davis, B. P., Dulbecco, R., Eisen, H. N., Ginsberg, H. s., and 
Wood, W. B. (1971) in Microbiology 2nd Ed, pp. 445-447, 
Harper and Row, San Francisco 
rJ 
VITA 
Gregory Scott Schultz 
Candidate for the Degree of 
Doctor of Philosophy 
Thesis: STUDIES ON THE RELATIONSHIP OF a-LACTALBUMIN AND MAMMARY 
CARCINOMAS 
Major Field: Biochemistry 
Biographical: 
Personal Data: Born in Enid, Oklahoma, September 30, 1949, 
the son of Edwin W. and Mary N. Schultz. 
Education: Graduated from Enid High School, Enid, Oklahoma, 
May, 1967; received Bachelor of Science degree in Bio-
chemistry from Oklahoma State University, Stillwater, 
Oklahoma, May, 1971; completed requirements for Doctor 
of Philosophy degree from Oklahoma State University, 
May, 1976. .. 
